<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33807572</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>19</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>3</Issue><PubDate><Year>2021</Year><Month>Mar</Month><Day>05</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>Oligodendrocyte Dysfunction in Amyotrophic Lateral Sclerosis: Mechanisms and Therapeutic Perspectives.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">565</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells10030565</ELocationID><Abstract><AbstractText>Myelin is the lipid-rich structure formed by oligodendrocytes (OLs) that wraps the axons in multilayered sheaths, assuring protection, efficient saltatory signal conduction and metabolic support to neurons. In the last few years, the impact of OL dysfunction and myelin damage has progressively received more attention and is now considered to be a major contributing factor to neurodegeneration in several neurological diseases, including amyotrophic lateral sclerosis (ALS). Upon OL injury, oligodendrocyte precursor cells (OPCs) of adult nervous tissue sustain the generation of new OLs for myelin reconstitution, but this spontaneous regeneration process fails to successfully counteract myelin damage. Of note, the functions of OPCs exceed the formation and repair of myelin, and also involve the trophic support to axons and the capability to exert an immunomodulatory role, which are particularly relevant in the context of neurodegeneration. In this review, we deeply analyze the impact of dysfunctional OLs in ALS pathogenesis. The possible mechanisms underlying OL degeneration, defective OPC maturation, and impairment in energy supply to motor neurons (MNs) have also been examined to provide insights on future therapeutic interventions. On this basis, we discuss the potential therapeutic utility in ALS of several molecules, based on their remyelinating potential or capability to enhance energy metabolism.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Raffaele</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-2734-5418</Identifier><AffiliationInfo><Affiliation>Department of Pharmacological and Biomolecular Sciences, Universit&#xe0; degli Studi di Milano, 20133 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boccazzi</LastName><ForeName>Marta</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-0844-1030</Identifier><AffiliationInfo><Affiliation>Department of Pharmacological and Biomolecular Sciences, Universit&#xe0; degli Studi di Milano, 20133 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fumagalli</LastName><ForeName>Marta</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-0158-842X</Identifier><AffiliationInfo><Affiliation>Department of Pharmacological and Biomolecular Sciences, Universit&#xe0; degli Studi di Milano, 20133 Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>GPR17ALS-1</GrantID><Agency>Fondazione AriSLA</Agency><Country/></Grant><Grant><GrantID>"Department of excellence" 2018-2022</GrantID><Agency>Italian Ministry of University and Research (MIUR)</Agency><Country/></Grant><Grant><GrantID>2019_BS_006</GrantID><Agency>Italian Multiple Sclerosis Foundation (FISM)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009836" MajorTopicYN="N">Oligodendroglia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">GPR17 receptor</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis (ALS)</Keyword><Keyword MajorTopicYN="N">glial cells</Keyword><Keyword MajorTopicYN="N">monocarboxylate transporter 1 (MCT1)</Keyword><Keyword MajorTopicYN="N">neurodegenerative disease</Keyword><Keyword MajorTopicYN="N">oligodendrocyte precursor cells (OPCs)</Keyword><Keyword MajorTopicYN="N">oligodendrocytes</Keyword><Keyword MajorTopicYN="N">regenerative medicine</Keyword><Keyword MajorTopicYN="N">remyelination</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>2</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>3</Day><Hour>1</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33807572</ArticleId><ArticleId IdType="pmc">PMC8000560</ArticleId><ArticleId IdType="doi">10.3390/cells10030565</ArticleId><ArticleId IdType="pii">cells10030565</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nave K.A., Werner H.B. Myelination of the Nervous System: Mechanisms and Functions. Annu. Rev. Cell Dev. Biol. 2014;30:503&#x2013;533. doi: 10.1146/annurev-cellbio-100913-013101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-cellbio-100913-013101</ArticleId><ArticleId IdType="pubmed">25288117</ArticleId></ArticleIdList></Reference><Reference><Citation>Kremer D., G&#xf6;ttle P., Hartung H.P., K&#xfc;ry P. Pushing Forward: Remyelination as the New Frontier in CNS Diseases. Trends Neurosci. 2016;39:246&#x2013;263. doi: 10.1016/j.tins.2016.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2016.02.004</ArticleId><ArticleId IdType="pubmed">26964504</ArticleId></ArticleIdList></Reference><Reference><Citation>Lubetzki C., Zalc B., Williams A., Stadelmann C., Stankoff B. Remyelination in Multiple Sclerosis: From Basic Science to Clinical Translation. Lancet Neurol. 2020;19:678&#x2013;688. doi: 10.1016/S1474-4422(20)30140-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30140-X</ArticleId><ArticleId IdType="pubmed">32702337</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine J.M., Reynolds R., Fawcett J.W. The Oligodendrocyte Precursor Cell in Health and Disease. Trends Neurosci. 2001;24:39&#x2013;47. doi: 10.1016/S0166-2236(00)01691-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0166-2236(00)01691-X</ArticleId><ArticleId IdType="pubmed">11163886</ArticleId></ArticleIdList></Reference><Reference><Citation>Dawson M.R.L., Polito A., Levine J.M., Reynolds R. NG2-Expressing Glial Progenitor Cells: An Abundant and Widespread Population of Cycling Cells in the Adult Rat CNS. Mol. Cell. Neurosci. 2003;24:476&#x2013;488. doi: 10.1016/S1044-7431(03)00210-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1044-7431(03)00210-0</ArticleId><ArticleId IdType="pubmed">14572468</ArticleId></ArticleIdList></Reference><Reference><Citation>Franklin R.J.M., Ffrench-Constant C. Regenerating CNS Myelin&#x2014;From Mechanisms to Experimental Medicines. Nat. Rev. Neurosci. 2017;18:753&#x2013;769. doi: 10.1038/nrn.2017.136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn.2017.136</ArticleId><ArticleId IdType="pubmed">29142295</ArticleId></ArticleIdList></Reference><Reference><Citation>Gruchot J., Weyers V., G&#xf6;ttle P., F&#xf6;rster M., Hartung H.P., K&#xfc;ry P., Kremer D. The Molecular Basis for Remyelination Failure in Multiple Sclerosis. Cells. 2019;8:825. doi: 10.3390/cells8080825.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8080825</ArticleId><ArticleId IdType="pmc">PMC6721708</ArticleId><ArticleId IdType="pubmed">31382620</ArticleId></ArticleIdList></Reference><Reference><Citation>Falc&#xe3;o A.M., van Bruggen D., Marques S., Meijer M., J&#xe4;kel S., Agirre E., Samudyata, Floriddia E.M., Vanichkina D.P., Ffrench-Constant C., et al. Disease-Specific Oligodendrocyte Lineage Cells Arise in Multiple Sclerosis. Nat. Med. 2018;24:1837&#x2013;1844. doi: 10.1038/s41591-018-0236-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0236-y</ArticleId><ArticleId IdType="pmc">PMC6544508</ArticleId><ArticleId IdType="pubmed">30420755</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrington E.P., Bergles D.E., Calabresi P.A. Immune Cell Modulation of Oligodendrocyte Lineage Cells. Neurosci. Lett. 2019:134601. doi: 10.1016/j.neulet.2019.134601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2019.134601</ArticleId><ArticleId IdType="pmc">PMC6981227</ArticleId><ArticleId IdType="pubmed">31693930</ArticleId></ArticleIdList></Reference><Reference><Citation>Stadelmann C., Timmler S., Barrantes-Freer A., Simons M. Myelin in the Central Nervous System: Structure, Function, and Pathology. Physiol. Rev. 2019;99:1381&#x2013;1431. doi: 10.1152/physrev.00031.2018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00031.2018</ArticleId><ArticleId IdType="pubmed">31066630</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitew S., Hay C.M., Peckham H., Xiao J., Koenning M., Emery B. Mechanisms Regulating the Development of Oligodendrocytes and Central Nervous System Myelin. Neuroscience. 2014;276:29&#x2013;47. doi: 10.1016/j.neuroscience.2013.11.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2013.11.029</ArticleId><ArticleId IdType="pubmed">24275321</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai J., Qi Y., Hu X., Tan M., Liu Z., Zhang J., Li Q., Sander M., Qiu M. Generation of Oligodendrocyte Precursor Cells from Mouse Dorsal Spinal Cord Independent of Nkx6 Regulation and Shh Signaling. Neuron. 2005;45:41&#x2013;53. doi: 10.1016/j.neuron.2004.12.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2004.12.028</ArticleId><ArticleId IdType="pubmed">15629701</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty M., Richardson W.D., Kessaris N. A Subset of Oligodendrocytes Generated from Radial Glia in the Dorsal Spinal Cord. Development. 2005;132:1951&#x2013;1959. doi: 10.1242/dev.01777.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.01777</ArticleId><ArticleId IdType="pubmed">15790969</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallstedt A., Klos J.M., Ericson J. Multiple Dorsoventral Origins of Oligodendrocyte Generation in the Spinal Cord and Hindbrain. Neuron. 2005;45:55&#x2013;67. doi: 10.1016/j.neuron.2004.12.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2004.12.026</ArticleId><ArticleId IdType="pubmed">15629702</ArticleId></ArticleIdList></Reference><Reference><Citation>Pringle N.P., Richardson W.D. A Singularity of PDGF Alpha-Receptor Expression in the Dorsoventral Axis of the Neural Tube May Define the Origin of the Oligodendrocyte Lineage. Development. 1993;117:525&#x2013;533.</Citation><ArticleIdList><ArticleId IdType="pubmed">8330523</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun T., Pringle N.P., Hardy A.P., Richardson W.D., Smith H.K. Pax6 Influences the Time and Site of Origin of Glial Precursors in the Ventral Neural Tube. Mol. Cell. Neurosci. 1998;12:228&#x2013;239. doi: 10.1006/mcne.1998.0711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/mcne.1998.0711</ArticleId><ArticleId IdType="pubmed">9828088</ArticleId></ArticleIdList></Reference><Reference><Citation>Kessaris N., Fogarty M., Iannarelli P., Grist M., Wegner M., Richardson W.D. Competing Waves of Oligodendrocytes in the Forebrain and Postnatal Elimination of an Embryonic Lineage. Nat. Neurosci. 2006;9:173&#x2013;179. doi: 10.1038/nn1620.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1620</ArticleId><ArticleId IdType="pmc">PMC6328015</ArticleId><ArticleId IdType="pubmed">16388308</ArticleId></ArticleIdList></Reference><Reference><Citation>Salmaso N., Jablonska B., Scafidi J., Vaccarino F.M., Gallo V. Neurobiology of Premature Brain Injury. Nat. Neurosci. 2014;17:341&#x2013;346. doi: 10.1038/nn.3604.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3604</ArticleId><ArticleId IdType="pmc">PMC4106480</ArticleId><ArticleId IdType="pubmed">24569830</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeung M.S.Y., Zdunek S., Bergmann O., Bernard S., Salehpour M., Alkass K., Perl S., Tisdale J., Ran Possnert G., Brundin L., et al. Dynamics of Oligodendrocyte Generation and Myelination in the Human Brain. Cell. 2014;159:766&#x2013;774. doi: 10.1016/j.cell.2014.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2014.10.011</ArticleId><ArticleId IdType="pubmed">25417154</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishiyama A., Komitova M., Suzuki R., Zhu X. Polydendrocytes (NG2 Cells): Multifunctional Cells with Lineage Plasticity. Nat. Rev. Neurosci. 2009;10:9&#x2013;22. doi: 10.1038/nrn2495.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn2495</ArticleId><ArticleId IdType="pubmed">19096367</ArticleId></ArticleIdList></Reference><Reference><Citation>Young K.M., Psachoulia K., Tripathi R.B., Dunn S.J., Cossell L., Attwell D., Tohyama K., Richardson W.D. Oligodendrocyte Dynamics in the Healthy Adult CNS: Evidence for Myelin Remodeling. Neuron. 2013;77:873&#x2013;885. doi: 10.1016/j.neuron.2013.01.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.01.006</ArticleId><ArticleId IdType="pmc">PMC3842597</ArticleId><ArticleId IdType="pubmed">23473318</ArticleId></ArticleIdList></Reference><Reference><Citation>McKenzie I.A., Ohayon D., Li H., De Faria J.P., Emery B., Tohyama K., Richardson W.D. Motor Skill Learning Requires Active Central Myelination. Science. 2014;346:318&#x2013;322. doi: 10.1126/science.1254960.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1254960</ArticleId><ArticleId IdType="pmc">PMC6324726</ArticleId><ArticleId IdType="pubmed">25324381</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato D., Wake H., Lee P.R., Tachibana Y., Ono R., Sugio S., Tsuji Y., Tanaka Y.H., Tanaka Y.R., Masamizu Y., et al. Motor Learning Requires Myelination to Reduce Asynchrony and Spontaneity in Neural Activity. Glia. 2020;68:193&#x2013;210. doi: 10.1002/glia.23713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23713</ArticleId><ArticleId IdType="pmc">PMC6899965</ArticleId><ArticleId IdType="pubmed">31465122</ArticleId></ArticleIdList></Reference><Reference><Citation>Franklin R.J.M., Fris&#xe9;n J., Lyons D.A. Revisiting Remyelination: Towards a Consensus on the Regeneration of CNS Myelin. Semin. Cell Dev. Biol. 2020 doi: 10.1016/j.semcdb.2020.09.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2020.09.009</ArticleId><ArticleId IdType="pubmed">33082115</ArticleId></ArticleIdList></Reference><Reference><Citation>El Waly B., Macchi M., Cayre M., Durbec P. Oligodendrogenesis in the Normal and Pathological Central Nervous System. Front. Neurosci. 2014;8:145. doi: 10.3389/fnins.2014.00145.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2014.00145</ArticleId><ArticleId IdType="pmc">PMC4054666</ArticleId><ArticleId IdType="pubmed">24971048</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradl M., Lassmann H. Oligodendrocytes: Biology and Pathology. Acta Neuropathol. 2010;119:37&#x2013;53. doi: 10.1007/s00401-009-0601-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-009-0601-5</ArticleId><ArticleId IdType="pmc">PMC2799635</ArticleId><ArticleId IdType="pubmed">19847447</ArticleId></ArticleIdList></Reference><Reference><Citation>Emery B., Lu Q.R. Transcriptional and Epigenetic Regulation of Oligodendrocyte Development and Myelination in the Central Nervous System. Cold Spring Harb. Perspect. Biol. 2015;7:1&#x2013;21. doi: 10.1101/cshperspect.a020461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a020461</ArticleId><ArticleId IdType="pmc">PMC4563712</ArticleId><ArticleId IdType="pubmed">26134004</ArticleId></ArticleIdList></Reference><Reference><Citation>Franklin R.J.M., Ffrench-Constant C. Remyelination in the CNS: From Biology to Therapy. Nat. Rev. Neurosci. 2008;9:839&#x2013;855. doi: 10.1038/nrn2480.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn2480</ArticleId><ArticleId IdType="pubmed">18931697</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciana P., Fumagalli M., Trincavelli M.L., Verderio C., Rosa P., Lecca D., Ferrario S., Parravicini C., Capra V., Gelosa P., et al. The Orphan Receptor GPR17 Identified as a New Dual Uracil Nucleotides/Cysteinyl-Leukotrienes Receptor. EMBO J. 2006;25:4615&#x2013;4627. doi: 10.1038/sj.emboj.7601341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.emboj.7601341</ArticleId><ArticleId IdType="pmc">PMC1589991</ArticleId><ArticleId IdType="pubmed">16990797</ArticleId></ArticleIdList></Reference><Reference><Citation>Lecca D., Trincavelli M.L., Gelosa P., Sironi L., Ciana P., Fumagalli M., Villa G., Verderio C., Grumelli C., Guerrini U., et al. The Recently Identified P2Y-like Receptor GPR17 Is a Sensor of Brain Damage and a New Target for Brain Repair. PLoS ONE. 2008;3:e3579. doi: 10.1371/journal.pone.0003579.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0003579</ArticleId><ArticleId IdType="pmc">PMC2570486</ArticleId><ArticleId IdType="pubmed">18974869</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceruti S., Vigan&#xf2; F., Boda E., Ferrario S., Magni G., Boccazzi M., Rosa P., Buffo A., Abbracchio M.P. Expression of the New P2Y-like Receptor GPR17 during Oligodendrocyte Precursor Cell Maturation Regulates Sensitivity to ATP-Induced Death. Glia. 2011;59:363&#x2013;378. doi: 10.1002/glia.21107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.21107</ArticleId><ArticleId IdType="pubmed">21264945</ArticleId></ArticleIdList></Reference><Reference><Citation>Fumagalli M., Daniele S., Lecca D., Lee P.R., Parravicini C., Fields R.D., Rosa P., Antonucci F., Verderio C., Trincavelli M.L., et al. Phenotypic Changes, Signaling Pathway, and Functional Correlates of GPR17-Expressing Neural Precursor Cells during Oligodendrocyte Differentiation. J. Biol. Chem. 2011;286:10593&#x2013;10604. doi: 10.1074/jbc.M110.162867.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.162867</ArticleId><ArticleId IdType="pmc">PMC3060511</ArticleId><ArticleId IdType="pubmed">21209081</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Wu H., Wang S., Koito H., Li J., Ye F., Hoang J., Escobar S.S., Gow A., Arnett H.A., et al. The Oligodendrocyte-Specific G Protein-Coupled Receptor GPR17 Is a Cell-Intrinsic Timer of Myelination. Nat. Neurosci. 2009;12:1398&#x2013;1406. doi: 10.1038/nn.2410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2410</ArticleId><ArticleId IdType="pmc">PMC2783566</ArticleId><ArticleId IdType="pubmed">19838178</ArticleId></ArticleIdList></Reference><Reference><Citation>Boda E., Vigan&#xf2; F., Rosa P., Fumagalli M., Labat-Gest V., Tempia F., Abbracchio M.P., Dimou L., Buffo A. The GPR17 Receptor in NG2 Expressing Cells: Focus on in Vivocell Maturation and Participation in Acute Trauma and Chronic Damage. Glia. 2011;59:1958&#x2013;1973. doi: 10.1002/glia.21237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.21237</ArticleId><ArticleId IdType="pubmed">21956849</ArticleId></ArticleIdList></Reference><Reference><Citation>Coppolino G.T., Marangon D., Negri C., Menichetti G., Fumagalli M., Gelosa P., Dimou L., Furlan R., Lecca D., Abbracchio M.P. Differential Local Tissue Permissiveness Influences the Final Fate of GPR17-Expressing Oligodendrocyte Precursors in Two Distinct Models of Demyelination. Glia. 2018:1118&#x2013;1130. doi: 10.1002/glia.23305.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23305</ArticleId><ArticleId IdType="pmc">PMC5900886</ArticleId><ArticleId IdType="pubmed">29424466</ArticleId></ArticleIdList></Reference><Reference><Citation>Fumagalli M., Bonfanti E., Daniele S., Zappelli E., Lecca D., Martini C., Trincavelli M.L., Abbracchio M.P. The Ubiquitin Ligase Mdm2 Controls Oligodendrocyte Maturation by Intertwining MTOR with G Protein-Coupled Receptor Kinase 2 in the Regulation of GPR17 Receptor Desensitization. Glia. 2015;63:2327&#x2013;2339. doi: 10.1002/glia.22896.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22896</ArticleId><ArticleId IdType="pubmed">26228571</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyler W.A., Jain M.R., Cifelli S.E., Li Q., Ku L., Feng Y., Li H., Wood T.L. Proteomic Identification of Novel Targets Regulated by the Mammalian Target of Rapamycin Pathway during Oligodendrocyte Differentiation. Glia. 2011;59:1754&#x2013;1769. doi: 10.1002/glia.21221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.21221</ArticleId><ArticleId IdType="pmc">PMC3174285</ArticleId><ArticleId IdType="pubmed">21858874</ArticleId></ArticleIdList></Reference><Reference><Citation>Marques S., Zeisel A., Codeluppi S., Van Bruggen D., Falc&#xe3;o A.M., Xiao L., Li H., H&#xe4;ring M., Hochgerner H., Romanov R.A., et al. Oligodendrocyte Heterogeneity in the Mouse Juvenile and Adult Central Nervous System. Science. 2016;352:1326&#x2013;1329. doi: 10.1126/science.aaf6463.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf6463</ArticleId><ArticleId IdType="pmc">PMC5221728</ArticleId><ArticleId IdType="pubmed">27284195</ArticleId></ArticleIdList></Reference><Reference><Citation>Simons M., Lyons D.A. Axonal Selection and Myelin Sheath Generation in the Central Nervous System. Curr. Opin. Cell Biol. 2013;25:512&#x2013;519. doi: 10.1016/j.ceb.2013.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceb.2013.04.007</ArticleId><ArticleId IdType="pubmed">23707197</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonetto G., Kamen Y., Evans K.A., K&#xe1;rad&#xf3;ttir R.T. Unraveling Myelin Plasticity. Front. Cell. Neurosci. 2020;14:156. doi: 10.3389/fncel.2020.00156.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2020.00156</ArticleId><ArticleId IdType="pmc">PMC7301701</ArticleId><ArticleId IdType="pubmed">32595455</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronzano R., Thetiot M., Lubetzki C., Desmazieres A. Myelin Plasticity and Repair: Neuro-Glial Choir Sets the Tuning. Front. Cell. Neurosci. 2020;14:42. doi: 10.3389/fncel.2020.00042.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2020.00042</ArticleId><ArticleId IdType="pmc">PMC7059744</ArticleId><ArticleId IdType="pubmed">32180708</ArticleId></ArticleIdList></Reference><Reference><Citation>Bechler M.E., Byrne L., Ffrench-Constant C. CNS Myelin Sheath Lengths Are an Intrinsic Property of Oligodendrocytes. Curr. Biol. 2015;25:2411&#x2013;2416. doi: 10.1016/j.cub.2015.07.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2015.07.056</ArticleId><ArticleId IdType="pmc">PMC4580335</ArticleId><ArticleId IdType="pubmed">26320951</ArticleId></ArticleIdList></Reference><Reference><Citation>Marisca R., Hoche T., Agirre E., Hoodless L.J., Barkey W., Auer F., Castelo-Branco G., Czopka T. Functionally Distinct Subgroups of Oligodendrocyte Precursor Cells Integrate Neural Activity and Execute Myelin Formation. Nat. Neurosci. 2020;23:363&#x2013;374. doi: 10.1038/s41593-019-0581-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0581-2</ArticleId><ArticleId IdType="pmc">PMC7292734</ArticleId><ArticleId IdType="pubmed">32066987</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortiz F.C., Habermacher C., Graciarena M., Houry P.Y., Nishiyama A., Oumesmar B.N., Angulo M.C. Neuronal Activity in Vivo Enhances Functional Myelin Repair. JCI Insight. 2019;4 doi: 10.1172/jci.insight.123434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.123434</ArticleId><ArticleId IdType="pmc">PMC6538342</ArticleId><ArticleId IdType="pubmed">30896448</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo M., Yin Y., Li D., Tang W., Liu Y., Pan L., Yu L., Tan B. Neuronal Activity-Dependent Myelin Repair Promotes Motor Function Recovery after Contusion Spinal Cord Injury. Brain Res. Bull. 2021;166:73&#x2013;81. doi: 10.1016/j.brainresbull.2020.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresbull.2020.11.009</ArticleId><ArticleId IdType="pubmed">33197536</ArticleId></ArticleIdList></Reference><Reference><Citation>Crawford A.H., Tripathi R.B., Richardson W.D., Franklin R.J.M. Developmental Origin of Oligodendrocyte Lineage Cells Determines Response to Demyelination and Susceptibility to Age-Associated Functional Decline. Cell Rep. 2016;15:761&#x2013;773. doi: 10.1016/j.celrep.2016.03.069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.03.069</ArticleId><ArticleId IdType="pmc">PMC4850420</ArticleId><ArticleId IdType="pubmed">27149850</ArticleId></ArticleIdList></Reference><Reference><Citation>Starikov L., Kottmann A.H. Diminished Ventral Oligodendrocyte Precursor Generation Results in the Subsequent Over-Production of Dorsal Oligodendrocyte Precursors of Aberrant Morphology and Function. Neuroscience. 2020;450:15&#x2013;28. doi: 10.1016/j.neuroscience.2020.05.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2020.05.027</ArticleId><ArticleId IdType="pubmed">32450295</ArticleId></ArticleIdList></Reference><Reference><Citation>Floriddia E.M., Louren&#xe7;o T., Zhang S., van Bruggen D., Hilscher M.M., Kukanja P., Gon&#xe7;alves dos Santos J.P., Alt&#x131;nk&#xf6;k M., Yokota C., Llorens-Bobadilla E., et al. Distinct Oligodendrocyte Populations Have Spatial Preference and Different Responses to Spinal Cord Injury. Nat. Commun. 2020;11 doi: 10.1038/s41467-020-19453-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19453-x</ArticleId><ArticleId IdType="pmc">PMC7673029</ArticleId><ArticleId IdType="pubmed">33203872</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivers L.E., Young K.M., Rizzi M., Jamen F., Psachoulia K., Wade A., Kessaris N., Richardson W.D. PDGFRA/NG2 Glia Generate Myelinating Oligodendrocytes and Piriform Projection Neurons in Adult Mice. Nat. Neurosci. 2008;11:1392&#x2013;1401. doi: 10.1038/nn.2220.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2220</ArticleId><ArticleId IdType="pmc">PMC3842596</ArticleId><ArticleId IdType="pubmed">18849983</ArticleId></ArticleIdList></Reference><Reference><Citation>Vigan&#xf2; F., M&#xf6;bius W., G&#xf6;tz M., Dimou L. Transplantation Reveals Regional Differences in Oligodendrocyte Differentiation in the Adult Brain. Nat. Neurosci. 2013;16:1370&#x2013;1372. doi: 10.1038/nn.3503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3503</ArticleId><ArticleId IdType="pubmed">23995069</ArticleId></ArticleIdList></Reference><Reference><Citation>Chittajallu R., Aguirre A., Gallo V. NG2-Positive Cells in the Mouse White and Grey Matter Display Distinct Physiological Properties. J. Physiol. 2004;561:109&#x2013;122. doi: 10.1113/jphysiol.2004.074252.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2004.074252</ArticleId><ArticleId IdType="pmc">PMC1665337</ArticleId><ArticleId IdType="pubmed">15358811</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Bruggen D., Agirre E., Castelo-Branco G. Single-Cell Transcriptomic Analysis of Oligodendrocyte Lineage Cells. Curr. Opin. Neurobiol. 2017;47:168&#x2013;175. doi: 10.1016/j.conb.2017.10.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conb.2017.10.005</ArticleId><ArticleId IdType="pubmed">29126015</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripathi R.B., Clarke L.E., Burzomato V., Kessaris N., Anderson P.N., Attwell D., Richardson W.D. Dorsally and Ventrally Derived Oligodendrocytes Have Similar Electrical Properties but Myelinate Preferred Tracts. J. Neurosci. 2011;31:6809&#x2013;6819. doi: 10.1523/JNEUROSCI.6474-10.2011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.6474-10.2011</ArticleId><ArticleId IdType="pmc">PMC4227601</ArticleId><ArticleId IdType="pubmed">21543611</ArticleId></ArticleIdList></Reference><Reference><Citation>J&#xe4;kel S., Agirre E., Mendanha Falc&#xe3;o A., van Bruggen D., Lee K.W., Knuesel I., Malhotra D., Ffrench-Constant C., Williams A., Castelo-Branco G. Altered Human Oligodendrocyte Heterogeneity in Multiple Sclerosis. Nature. 2019;566:543&#x2013;547. doi: 10.1038/s41586-019-0903-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-0903-2</ArticleId><ArticleId IdType="pmc">PMC6544546</ArticleId><ArticleId IdType="pubmed">30747918</ArticleId></ArticleIdList></Reference><Reference><Citation>Nave K.A. Myelination and Support of Axonal Integrity by Glia. Nature. 2010;468:244&#x2013;252. doi: 10.1038/nature09614.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09614</ArticleId><ArticleId IdType="pubmed">21068833</ArticleId></ArticleIdList></Reference><Reference><Citation>Saab A.S., Nave K.A. Myelin Dynamics: Protecting and Shaping Neuronal Functions. Curr. Opin. Neurobiol. 2017;47:104&#x2013;112. doi: 10.1016/j.conb.2017.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conb.2017.09.013</ArticleId><ArticleId IdType="pubmed">29065345</ArticleId></ArticleIdList></Reference><Reference><Citation>Berndt N., Holzh&#xfc;tter H.G. The High Energy Demand of Neuronal Cells Caused by Passive Leak Currents Is Not a Waste of Energy. Cell Biochem. Biophys. 2013;67:527&#x2013;535. doi: 10.1007/s12013-013-9538-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12013-013-9538-3</ArticleId><ArticleId IdType="pubmed">23479331</ArticleId></ArticleIdList></Reference><Reference><Citation>Saez I., Duran J., Sinadinos C., Beltran A., Yanes O., Tevy M.F., Mart&#xed;nez-Pons C., Mil&#xe1;n M., Guinovart J.J. Neurons Have an Active Glycogen Metabolism That Contributes to Tolerance to Hypoxia. J. Cereb. Blood Flow Metab. 2014;34:945&#x2013;955. doi: 10.1038/jcbfm.2014.33.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jcbfm.2014.33</ArticleId><ArticleId IdType="pmc">PMC4050236</ArticleId><ArticleId IdType="pubmed">24569689</ArticleId></ArticleIdList></Reference><Reference><Citation>F&#xfc;nfschilling U., Supplie L.M., Mahad D., Boretius S., Saab A.S., Edgar J., Brinkmann B.G., Kassmann C.M., Tzvetanova I.D., M&#xf6;bius W., et al. Glycolytic Oligodendrocytes Maintain Myelin and Long-Term Axonal Integrity. Nature. 2012;485:517&#x2013;521. doi: 10.1038/nature11007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11007</ArticleId><ArticleId IdType="pmc">PMC3613737</ArticleId><ArticleId IdType="pubmed">22622581</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y., Morrison B.M., Li Y., Lengacher S., Farah M.H., Hoffman P.N., Liu Y., Tsingalia A., Jin L., Zhang P.-W., et al. Oligodendroglia Metabolically Support Axons and Contribute to Neurodegeneration. Nature. 2012;487:443&#x2013;448. doi: 10.1038/nature11314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11314</ArticleId><ArticleId IdType="pmc">PMC3408792</ArticleId><ArticleId IdType="pubmed">22801498</ArticleId></ArticleIdList></Reference><Reference><Citation>Niu J., Li T., Yi C., Huang N., Koulakoff A., Weng C., Li C., Zhao C.J., Giaume C., Xiao L. Connexin-Based Channels Contribute to Metabolic Pathways in the Oligodendroglial Lineage. J. Cell Sci. 2016;129:1902&#x2013;1914. doi: 10.1242/jcs.178731.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.178731</ArticleId><ArticleId IdType="pubmed">27006115</ArticleId></ArticleIdList></Reference><Reference><Citation>Markoullis K., Sargiannidou I., Schiza N., Roncaroli F., Reynolds R., Kleopa K.A. Oligodendrocyte Gap Junction Loss and Disconnection From Reactive Astrocytes in Multiple Sclerosis Gray Matter. J. Neuropathol. Exp. Neurol. 2014;73:865&#x2013;879. doi: 10.1097/NEN.0000000000000106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0000000000000106</ArticleId><ArticleId IdType="pubmed">25101702</ArticleId></ArticleIdList></Reference><Reference><Citation>Markoullis K., Sargiannidou I., Gardner C., Hadjisavvas A., Reynolds R., Kleopa K.A. Disruption of Oligodendrocyte Gap Junctions in Experimental Autoimmune Encephalomyelitis. Glia. 2012;60:1053&#x2013;1066. doi: 10.1002/glia.22334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22334</ArticleId><ArticleId IdType="pubmed">22461072</ArticleId></ArticleIdList></Reference><Reference><Citation>Markoullis K., Sargiannidou I., Schiza N., Hadjisavvas A., Roncaroli F., Reynolds R., Kleopa K.A. Gap Junction Pathology in Multiple Sclerosis Lesions and Normal-Appearing White Matter. Acta Neuropathol. 2012;123:873&#x2013;886. doi: 10.1007/s00401-012-0978-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-0978-4</ArticleId><ArticleId IdType="pubmed">22484441</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrison B.M., Lee Y., Rothstein J.D. Oligodendroglia: Metabolic Supporters of Axons. Trends Cell Biol. 2013;23:644&#x2013;651. doi: 10.1016/j.tcb.2013.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2013.07.007</ArticleId><ArticleId IdType="pmc">PMC3842360</ArticleId><ArticleId IdType="pubmed">23988427</ArticleId></ArticleIdList></Reference><Reference><Citation>Saab A.S., Tzvetavona I.D., Trevisiol A., Baltan S., Dibaj P., Kusch K., M&#xf6;bius W., Goetze B., Jahn H.M., Huang W., et al. Oligodendroglial NMDA Receptors Regulate Glucose Import and Axonal Energy Metabolism. Neuron. 2016;91:119&#x2013;132. doi: 10.1016/j.neuron.2016.05.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.05.016</ArticleId><ArticleId IdType="pubmed">27292539</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips T., Mironova Y.A., Jouroukhin Y., Chew J., Vidensky S., Farah M.H., Pletnikov M.V., Bergles D.E., Morrison B.M., Rothstein J.D. MCT1 Deletion in Oligodendrocyte Lineage Cells Causes Late-Onset Hypomyelination and Axonal Degeneration. Cell Rep. 2021;34:108610. doi: 10.1016/j.celrep.2020.108610.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.108610</ArticleId><ArticleId IdType="pmc">PMC8020895</ArticleId><ArticleId IdType="pubmed">33440165</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeis T., Enz L., Schaeren-Wiemers N. The Immunomodulatory Oligodendrocyte. Brain Res. 2016;1641:139&#x2013;148. doi: 10.1016/j.brainres.2015.09.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2015.09.021</ArticleId><ArticleId IdType="pubmed">26423932</ArticleId></ArticleIdList></Reference><Reference><Citation>Peferoen L., Kipp M., van der Valk P., van Noort J.M., Amor S. Oligodendrocyte-Microglia Cross-Talk in the Central Nervous System. Immunology. 2014;141:302&#x2013;313. doi: 10.1111/imm.12163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.12163</ArticleId><ArticleId IdType="pmc">PMC3930369</ArticleId><ArticleId IdType="pubmed">23981039</ArticleId></ArticleIdList></Reference><Reference><Citation>Boccazzi M., Van Steenwinckel J., Schang A., Faivre V., Le Charpentier T., Bokobza C., Csaba Z., Verderio C., Fumagalli M., Mani S., et al. The Immune-Inflammatory Response of Oligodendrocytes in a Murine Model of Preterm White Matter Injury: The Role of TLR3 Activation. Cell Death Dis. 2021 doi: 10.1038/s41419-021-03446-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-021-03446-9</ArticleId><ArticleId IdType="pmc">PMC7870670</ArticleId><ArticleId IdType="pubmed">33558485</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Aguzzi A. NG2 Glia Are Required for Maintaining Microglia Homeostatic State. Glia. 2020;68:345&#x2013;355. doi: 10.1002/glia.23721.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23721</ArticleId><ArticleId IdType="pubmed">31518022</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S., Wang Q., Yang Q., Gu H., Yin Y., Li Y., Hou J., Chen R., Sun Q., Sun Y., et al. NG2 Glia Regulate Brain Innate Immunity via TGF-&#x392;2/TGFBR2 Axis. BMC Med. 2019;17:204. doi: 10.1186/s12916-019-1439-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-019-1439-x</ArticleId><ArticleId IdType="pmc">PMC6857135</ArticleId><ArticleId IdType="pubmed">31727112</ArticleId></ArticleIdList></Reference><Reference><Citation>Goncalves M.B., Wu Y., Trigo D., Clarke E., Malmqvist T., Grist J., Hobbs C., Carlstedt T.P., Corcoran J.P.T. Retinoic Acid Synthesis by NG2 Expressing Cells Promotes a Permissive Environment for Axonal Outgrowth. Neurobiol. Dis. 2018;111:70&#x2013;79. doi: 10.1016/j.nbd.2017.12.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2017.12.016</ArticleId><ArticleId IdType="pmc">PMC5803510</ArticleId><ArticleId IdType="pubmed">29274429</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnett H.A., Mason J., Marino M., Suzuki K., Matsushima G.K., Ting J.P.Y. TNF&#x3b1; Promotes Proliferation of Oligodendrocyte Progenitors and Remyelination. Nat. Neurosci. 2001;4:1116&#x2013;1122. doi: 10.1038/nn738.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn738</ArticleId><ArticleId IdType="pubmed">11600888</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergsteinsdottir K., Brennan A., Jessen K.R., Mirsky R. In the Presence of Dexamethasone, &#x3b3; Interferon Induces Rat Oligodendrocytes to Express Major Histocompatibility Complex Class II Molecules. Proc. Natl. Acad. Sci. USA. 1992;89:9054&#x2013;9058. doi: 10.1073/pnas.89.19.9054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.89.19.9054</ArticleId><ArticleId IdType="pmc">PMC50063</ArticleId><ArticleId IdType="pubmed">1409602</ArticleId></ArticleIdList></Reference><Reference><Citation>Massa P.T., Ozato K., McFarlin D.E. Cell Type-Specific Regulation of Major Histocompatibility Complex (MHC) Class I Gene Expression in Astrocytes, Oligodendrocytes, and Neurons. Glia. 1993;8:201&#x2013;207. doi: 10.1002/glia.440080307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.440080307</ArticleId><ArticleId IdType="pubmed">8225560</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirby L., Jin J., Cardona J.G., Smith M.D., Martin K.A., Wang J., Strasburger H., Herbst L., Alexis M., Karnell J., et al. Oligodendrocyte Precursor Cells Present Antigen and Are Cytotoxic Targets in Inflammatory Demyelination. Nat. Commun. 2019;10:3887. doi: 10.1038/s41467-019-11638-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-11638-3</ArticleId><ArticleId IdType="pmc">PMC6715717</ArticleId><ArticleId IdType="pubmed">31467299</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirby L., Castelo-Branco G. Crossing Boundaries: Interplay between the Immune System and Oligodendrocyte Lineage Cells. Semin. Cell Dev. Biol. 2020 doi: 10.1016/j.semcdb.2020.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2020.10.013</ArticleId><ArticleId IdType="pubmed">33162336</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown R.H., Al-Chalabi A. Amyotrophic Lateral Sclerosis. N. Engl. J. Med. 2017;377:162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S., Sayana P., Zhang X., Le W. Genetics of Amyotrophic Lateral Sclerosis: An Update. Mol. Neurodegener. 2013;8:1&#x2013;15. doi: 10.1186/1750-1326-8-28.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-8-28</ArticleId><ArticleId IdType="pmc">PMC3766231</ArticleId><ArticleId IdType="pubmed">23941283</ArticleId></ArticleIdList></Reference><Reference><Citation>Boylan K. Familial Amyotrophic Lateral Sclerosis. Neurol. Clin. 2015;33:807&#x2013;830. doi: 10.1016/j.ncl.2015.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2015.07.001</ArticleId><ArticleId IdType="pmc">PMC4670044</ArticleId><ArticleId IdType="pubmed">26515623</ArticleId></ArticleIdList></Reference><Reference><Citation>King A.E., Woodhouse A., Kirkcaldie M.T.K., Vickers J.C. Excitotoxicity in ALS: Overstimulation, or Overreaction? Exp. Neurol. 2016;275:162&#x2013;171. doi: 10.1016/j.expneurol.2015.09.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2015.09.019</ArticleId><ArticleId IdType="pubmed">26584004</ArticleId></ArticleIdList></Reference><Reference><Citation>Filipi T., Hermanova Z., Tureckova J., Vanatko O., Anderova M. Glial Cells&#x2014;The Strategic Targets in Amyotrophic Lateral Sclerosis Treatment. J. Clin. Med. 2020;9:261. doi: 10.3390/jcm9010261.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9010261</ArticleId><ArticleId IdType="pmc">PMC7020059</ArticleId><ArticleId IdType="pubmed">31963681</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Wang F. Role of Neuroinflammation in Amyotrophic Lateral Sclerosis: Cellular Mechanisms and Therapeutic Implications. Front. Immunol. 2017;8:1005. doi: 10.3389/fimmu.2017.01005.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01005</ArticleId><ArticleId IdType="pmc">PMC5567007</ArticleId><ArticleId IdType="pubmed">28871262</ArticleId></ArticleIdList></Reference><Reference><Citation>McCauley M.E., Baloh R.H. Inflammation in ALS/FTD Pathogenesis. Acta Neuropathol. 2019;137:715&#x2013;730. doi: 10.1007/s00401-018-1933-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1933-9</ArticleId><ArticleId IdType="pmc">PMC6482122</ArticleId><ArticleId IdType="pubmed">30465257</ArticleId></ArticleIdList></Reference><Reference><Citation>Saez-Atienzar S., Bandres-Ciga S., Langston R.G., Kim J.J., Choi S.W., Reynolds R.H., Abramzon Y., Dewan R., Ahmed S., Landers J.E., et al. Genetic Analysis of Amyotrophic Lateral Sclerosis Identifies Contributing Pathways and Cell Types. Sci. Adv. 2021;7:eabd9036. doi: 10.1126/sciadv.abd9036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abd9036</ArticleId><ArticleId IdType="pmc">PMC7810371</ArticleId><ArticleId IdType="pubmed">33523907</ArticleId></ArticleIdList></Reference><Reference><Citation>Stieber A., Gonatas J.O., Gonatas N.K. Aggregates of Mutant Protein Appear Progressively in Dendrites, in Periaxonal Processes of Oligodendrocytes, and in Neuronal and Astrocytic Perikarya of Mice Expressing the SOD1(G93A) Mutation of Familial Amyotrophic Lateral Sclerosis. J. Neurol. Sci. 2000;177:114&#x2013;123. doi: 10.1016/S0022-510X(00)00351-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(00)00351-8</ArticleId><ArticleId IdType="pubmed">10980307</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang S.H., Li Y., Fukaya M., Lorenzini I., Cleveland D.W., Ostrow L.W., Rothstein J.D., Bergles D.E. Degeneration and Impaired Regeneration of Gray Matter Oligodendrocytes in Amyotrophic Lateral Sclerosis. Nat. Neurosci. 2013;16:571&#x2013;579. doi: 10.1038/nn.3357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3357</ArticleId><ArticleId IdType="pmc">PMC3637847</ArticleId><ArticleId IdType="pubmed">23542689</ArticleId></ArticleIdList></Reference><Reference><Citation>Gatto R.G., Li W., Magin R.L. Diffusion Tensor Imaging Identifies Presymptomatic Axonal Degeneration in the Spinal Cord of ALS Mice. Brain Res. 2018;1679:45&#x2013;52. doi: 10.1016/j.brainres.2017.11.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2017.11.017</ArticleId><ArticleId IdType="pubmed">29175489</ArticleId></ArticleIdList></Reference><Reference><Citation>Mollink J., Hiemstra M., Miller K.L., Huszar I.N., Jenkinson M., Raaphorst J., Wiesmann M., Ansorge O., Pallebage-Gamarallage M., van Cappellen van Walsum A.M. White Matter Changes in the Perforant Path Area in Patients with Amyotrophic Lateral Sclerosis. Neuropathol. Appl. Neurobiol. 2019;45:570&#x2013;585. doi: 10.1111/nan.12555.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12555</ArticleId><ArticleId IdType="pmc">PMC6852107</ArticleId><ArticleId IdType="pubmed">31002412</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorente Pons A., Higginbottom A., Cooper-Knock J., Alrafiah A., Alofi E., Kirby J., Shaw P.J., Wood J.D., Highley J.R. Oligodendrocyte Pathology Exceeds Axonal Pathology in White Matter in Human Amyotrophic Lateral Sclerosis. J. Pathol. 2020;251:262&#x2013;271. doi: 10.1002/path.5455.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.5455</ArticleId><ArticleId IdType="pubmed">32391572</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips T., Bento-Abreu A., Nonneman A., Haeck W., Staats K., Geelen V., Hersmus N., K&#xfc;sters B., Van Den Bosch L., Van Damme P., et al. Oligodendrocyte Dysfunction in the Pathogenesis of Amyotrophic Lateral Sclerosis. Brain. 2013;136:471&#x2013;482. doi: 10.1093/brain/aws339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aws339</ArticleId><ArticleId IdType="pmc">PMC3572934</ArticleId><ArticleId IdType="pubmed">23378219</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalra S., M&#xfc;ller H.-P., Ishaque A., Zinman L., Korngut L., Genge A., Beaulieu C., Frayne R., Graham S., Kassubek J. A Prospective Harmonized Multicentre DTI Study of Cerebral White Matter Degeneration in ALS. Neurology. 2020 doi: 10.1212/WNL.0000000000010235.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010235</ArticleId><ArticleId IdType="pmc">PMC7668555</ArticleId><ArticleId IdType="pubmed">32646955</ArticleId></ArticleIdList></Reference><Reference><Citation>Niebroj-Dobosz I., Rafa&#x142;owska J., Fidzia&#xf1;ska A., Gadamski R., Grieb P. Myelin Composition of Spinal Cord in a Model of Amyotrophic Lateral Sclerosis (ALS) in SOD1 G93A Transgenic Rats. Folia Neuropathol. 2007;45:236&#x2013;241.</Citation><ArticleIdList><ArticleId IdType="pubmed">18176898</ArticleId></ArticleIdList></Reference><Reference><Citation>Gatto R.G., Mustafi S.M., Amin M.Y., Mareci T.H., Wu Y.C., Magin R.L. Neurite Orientation Dispersion and Density Imaging Can Detect Presymptomatic Axonal Degeneration in the Spinal Cord of ALS Mice. Funct. Neurol. 2018;33:155&#x2013;163. doi: 10.11138/FNeur/2018.33.3.155.</Citation><ArticleIdList><ArticleId IdType="doi">10.11138/FNeur/2018.33.3.155</ArticleId><ArticleId IdType="pmc">PMC7212765</ArticleId><ArticleId IdType="pubmed">30457969</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonfanti E., Bonifacino T., Raffaele S., Milanese M., Morgante E., Bonanno G., Abbracchio M.P., Fumagalli M. Abnormal Upregulation of GPR17 Receptor Contributes to Oligodendrocyte Dysfunction in SOD1 G93A Mice. Int. J. Mol. Sci. 2020;21:2395. doi: 10.3390/ijms21072395.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21072395</ArticleId><ArticleId IdType="pmc">PMC7177925</ArticleId><ArticleId IdType="pubmed">32244295</ArticleId></ArticleIdList></Reference><Reference><Citation>Clement A.M., Nguyen M.D., Roberts E.A., Garcia M.L., Boill&#xe9;e S., Rule M., McMahon A.P., Doucette W., Siwek D., Ferrante R.J., et al. Wild-Type Nonneuronal Cells Extend Survival of SOD1 Mutant Motor Neurons in ALS Mice. Science. 2003;302:113&#x2013;117. doi: 10.1126/science.1086071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1086071</ArticleId><ArticleId IdType="pubmed">14526083</ArticleId></ArticleIdList></Reference><Reference><Citation>Eykens C., Rossaert E., Duqu&#xe9; S., Ru&#xe9; L., Bento-Abreu A., Hersmus N., Lenaerts A., Kerstens A., Corthout N., Munck S., et al. AAV9-Mediated Gene Delivery of MCT1 to Oligodendrocytes Does Not Provide a Therapeutic Benefit in a Mouse Model of ALS. Mol. Ther. Methods Clin. Dev. 2021;20:508&#x2013;519. doi: 10.1016/j.omtm.2021.01.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtm.2021.01.006</ArticleId><ArticleId IdType="pmc">PMC7878966</ArticleId><ArticleId IdType="pubmed">33614825</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S., Chung A.Y., Na J.E., Lee S.J., Jeong S.H., Kim E., Sun W., Rhyu I.J., Park H.C. Myelin Degeneration Induced by Mutant Superoxide Dismutase 1 Accumulation Promotes Amyotrophic Lateral Sclerosis. Glia. 2019;67:1910&#x2013;1921. doi: 10.1002/glia.23669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23669</ArticleId><ArticleId IdType="pubmed">31290185</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagai M., Re D.B., Nagata T., Chalazonitis A., Jessell T.M., Wichterle H., Przedborski S. Astrocytes Expressing ALS-Linked Mutated SOD1 Release Factors Selectively Toxic to Motor Neurons. Nat. Neurosci. 2007;10:615&#x2013;622. doi: 10.1038/nn1876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1876</ArticleId><ArticleId IdType="pmc">PMC3799799</ArticleId><ArticleId IdType="pubmed">17435755</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraiuolo L., Meyer K., Sherwood T.W., Vick J., Likhite S., Frakes A., Miranda C.J., Braun L., Heath P.R., Pineda R., et al. Oligodendrocytes Contribute to Motor Neuron Death in ALS via SOD1-Dependent Mechanism. Proc. Natl. Acad. Sci. USA. 2016;113:E6496&#x2013;E6505. doi: 10.1073/pnas.1607496113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1607496113</ArticleId><ArticleId IdType="pmc">PMC5081600</ArticleId><ArticleId IdType="pubmed">27688759</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I.R.A., Ansorge O., Strong M., Bilbao J., Zinman L., Ang L.C., Baker M., Stewart H., Eisen A., Rademakers R., et al. Pathological Heterogeneity in Amyotrophic Lateral Sclerosis with FUS Mutations: Two Distinct Patterns Correlating with Disease Severity and Mutation. Acta Neuropathol. 2011;122:87&#x2013;98. doi: 10.1007/s00401-011-0838-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-011-0838-7</ArticleId><ArticleId IdType="pmc">PMC3319073</ArticleId><ArticleId IdType="pubmed">21604077</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J., Arai K., Del Tredici K., Toledo J.B., Robinson J.L., Lee E.B., Kuwabara S., Shibuya K., Irwin D.J., Fang L., et al. TDP-43 Pathology and Neuronal Loss in Amyotrophic Lateral Sclerosis Spinal Cord. Acta Neuropathol. 2014;128:423&#x2013;437. doi: 10.1007/s00401-014-1299-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1299-6</ArticleId><ArticleId IdType="pmc">PMC4384652</ArticleId><ArticleId IdType="pubmed">24916269</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J., Blair I.P., Tripathi V.B., Hu X., Vance C., Rogelj B., Ackerley S., Durnall J.C., Williams K.L., Buratti E., et al. TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis. Science. 2008;319:1668&#x2013;1672. doi: 10.1126/science.1154584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1154584</ArticleId><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeuchi R., Tada M., Shiga A., Toyoshima Y., Konno T., Sato T., Nozaki H., Kato T., Horie M., Shimizu H., et al. Heterogeneity of Cerebral TDP-43 Pathology in Sporadic Amyotrophic Lateral Sclerosis: Evidence for Clinico-Pathologic Subtypes. Acta Neuropathol. Commun. 2016;4:61. doi: 10.1186/s40478-016-0335-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0335-2</ArticleId><ArticleId IdType="pmc">PMC4918136</ArticleId><ArticleId IdType="pubmed">27338935</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli E.T., Lasseigne B.N., Petrovski S., Sapp P.C., Dion P.A., Leblond C.S., Couthouis J., Lu Y.F., Wang Q., Krueger B.J., et al. Exome Sequencing in Amyotrophic Lateral Sclerosis Identifies Risk Genes and Pathways. Science. 2015;347:1436&#x2013;1441. doi: 10.1126/science.aaa3650.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa3650</ArticleId><ArticleId IdType="pmc">PMC4437632</ArticleId><ArticleId IdType="pubmed">25700176</ArticleId></ArticleIdList></Reference><Reference><Citation>Maruyama H., Morino H., Ito H., Izumi Y., Kato H., Watanabe Y., Kinoshita Y., Kamada M., Nodera H., Suzuki H., et al. Mutations of Optineurin in Amyotrophic Lateral Sclerosis. Nature. 2010;465:223&#x2013;226. doi: 10.1038/nature08971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08971</ArticleId><ArticleId IdType="pubmed">20428114</ArticleId></ArticleIdList></Reference><Reference><Citation>Markovinovic A., Cimbro R., Ljutic T., Kriz J., Rogelj B., Munitic I. Optineurin in Amyotrophic Lateral Sclerosis: Multifunctional Adaptor Protein at the Crossroads of Different Neuroprotective Mechanisms. Prog. Neurobiol. 2017;154:1&#x2013;20. doi: 10.1016/j.pneurobio.2017.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2017.04.005</ArticleId><ArticleId IdType="pubmed">28456633</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito Y., Ofengeim D., Najafov A., Das S., Saberi S., Li Y., Hitomi J., Zhu H., Chen H., Mayo L., et al. RIPK1 Mediates Axonal Degeneration by Promoting Inflammation and Necroptosis in ALS. Science. 2016;353:603&#x2013;608. doi: 10.1126/science.aaf6803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf6803</ArticleId><ArticleId IdType="pmc">PMC5444917</ArticleId><ArticleId IdType="pubmed">27493188</ArticleId></ArticleIdList></Reference><Reference><Citation>Barton S.K., Gregory J.M., Chandran S., Turner B.J. Could an Impairment in Local Translation of MRNAs in Glia Be Contributing to Pathogenesis in ALS? Front. Mol. Neurosci. 2019;12:124. doi: 10.3389/fnmol.2019.00124.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00124</ArticleId><ArticleId IdType="pmc">PMC6536688</ArticleId><ArticleId IdType="pubmed">31164803</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoch-Kraft P., Trotter J., Gonsior C. Missing in Action: Dysfunctional RNA Metabolism in Oligodendroglial Cells as a Contributor to Neurodegenerative Diseases? Neurochem. Res. 2020;45:566&#x2013;579. doi: 10.1007/s11064-019-02763-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-019-02763-y</ArticleId><ArticleId IdType="pubmed">30843138</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Ho W.Y., Lim K., Feng J., Tucker-Kellogg G., Nave K.A., Ling S.C. Cell-Autonomous Requirement of TDP-43, an ALS/FTD Signature Protein, for Oligodendrocyte Survival and Myelination. Proc. Natl. Acad. Sci. USA. 2018;115:E10941&#x2013;E10950. doi: 10.1073/pnas.1809821115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1809821115</ArticleId><ArticleId IdType="pmc">PMC6243235</ArticleId><ArticleId IdType="pubmed">30373824</ArticleId></ArticleIdList></Reference><Reference><Citation>White M.A., Kim E., Duffy A., Adalbert R., Phillips B.U., Peters O.M., Stephenson J., Yang S., Massenzio F., Lin Z., et al. TDP-43 Gains Function Due to Perturbed Autoregulation in a Tardbp Knock-in Mouse Model of ALS-FTD. Nat. Neurosci. 2018;21:552&#x2013;563. doi: 10.1038/s41593-018-0113-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0113-5</ArticleId><ArticleId IdType="pmc">PMC5884423</ArticleId><ArticleId IdType="pubmed">29556029</ArticleId></ArticleIdList></Reference><Reference><Citation>Scekic-Zahirovic J., El Oussini H., Mersmann S., Drenner K., Wagner M., Sun Y., Allmeroth K., Dieterl&#xe9; S., Sinniger J., Dirrig-Grosch S., et al. Motor Neuron Intrinsic and Extrinsic Mechanisms Contribute to the Pathogenesis of FUS-Associated Amyotrophic Lateral Sclerosis. Acta Neuropathol. 2017;133:887&#x2013;906. doi: 10.1007/s00401-017-1687-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1687-9</ArticleId><ArticleId IdType="pmc">PMC5427169</ArticleId><ArticleId IdType="pubmed">28243725</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzman K.M., Brink L.E., Rodriguez-Bey G., Bodnar R.J., Kuang L., Xing B., Sullivan M., Park H.J., Koppes E., Zhu H., et al. Conditional Depletion of Fus in Oligodendrocytes Leads to Motor Hyperactivity and Increased Myelin Deposition Associated with Akt and Cholesterol Activation. Glia. 2020;68:2040&#x2013;2056. doi: 10.1002/glia.23825.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23825</ArticleId><ArticleId IdType="pmc">PMC7772959</ArticleId><ArticleId IdType="pubmed">32187401</ArticleId></ArticleIdList></Reference><Reference><Citation>Emery B. Regulation of Oligodendrocyte Differentiation and Myelination. Science. 2010;330:779&#x2013;782. doi: 10.1126/science.1190927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1190927</ArticleId><ArticleId IdType="pubmed">21051629</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S., Sdrulla A., Johnson J.E., Yokota Y., Barres B.A. A Role for the Helix-Loop-Helix Protein Id2 in the Control of Oligodendrocyte Development. Neuron. 2001;29:603&#x2013;614. doi: 10.1016/S0896-6273(01)00237-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(01)00237-9</ArticleId><ArticleId IdType="pubmed">11301021</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Argaw A.T., Gurfein B.T., Zameer A., Snyder B.J., Ge C., Lu Q.R., Rowitch D.H., Raine C.S., Brosnan C.F., et al. Notch1 Signaling Plays a Role in Regulating Precursor Differentiation during CNS Remyelination. Proc. Natl. Acad. Sci. USA. 2009;106:19162&#x2013;19167. doi: 10.1073/pnas.0902834106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0902834106</ArticleId><ArticleId IdType="pmc">PMC2776461</ArticleId><ArticleId IdType="pubmed">19855010</ArticleId></ArticleIdList></Reference><Reference><Citation>John G.R., Shankar S.L., Shafit-Zagardo B., Massimi A., Lee S.C., Raine C.S., Brosnan C.F. Multiple Sclerosis: Re-Expression of a Developmental Pathway That Restricts Oligodendrocyte Maturation. Nat. Med. 2002;8:1115&#x2013;1121. doi: 10.1038/nm781.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm781</ArticleId><ArticleId IdType="pubmed">12357247</ArticleId></ArticleIdList></Reference><Reference><Citation>Stidworthy M.F. Notch1 and Jagged1 Are Expressed after CNS Demyelination, but Are Not a Major Rate-Determining Factor during Remyelination. Brain. 2004;127:1928&#x2013;1941. doi: 10.1093/brain/awh217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awh217</ArticleId><ArticleId IdType="pubmed">15289265</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan H., Zhao J., Yan J., Du G., Fu Q., Shi J., Yang Y., Du X., Bai X. Effect of Notch1 Gene on Remyelination in Multiple Sclerosis in Mouse Models of Acute Demyelination. J. Cell. Biochem. 2018;119:9284&#x2013;9294. doi: 10.1002/jcb.27197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.27197</ArticleId><ArticleId IdType="pubmed">30010211</ArticleId></ArticleIdList></Reference><Reference><Citation>Eykens C., Nonneman A., Jensen C., Iavarone A., Van Damme P., Van Den Bosch L., Robberecht W. Conditional Deletion of Id2 or Notch1 in Oligodendrocyte Progenitor Cells Does Not Ameliorate Disease Outcome in SOD1G93A Mice. Neurobiol. Aging. 2018;68:1&#x2013;4. doi: 10.1016/j.neurobiolaging.2018.03.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2018.03.026</ArticleId><ArticleId IdType="pmc">PMC5998381</ArticleId><ArticleId IdType="pubmed">29689424</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C., Li D., Lv C., Gao Z., Qi Y., Wu H., Tian Y., Guo Y. Activation of the Notch Signaling Pathway and Cellular Localization of Notch Signaling Molecules in the Spinal Cord of SOD1-G93A ALS Model Mice. Neuroscience. 2020;432:84&#x2013;93. doi: 10.1016/j.neuroscience.2020.02.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2020.02.034</ArticleId><ArticleId IdType="pubmed">32114100</ArticleId></ArticleIdList></Reference><Reference><Citation>Lecca D., Raffaele S., Abbracchio M.P., Fumagalli M. Regulation and Signaling of the GPR17 Receptor in Oligodendroglial Cells. Glia. 2020;2:1&#x2013;11. doi: 10.1002/glia.23807.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23807</ArticleId><ArticleId IdType="pubmed">32086854</ArticleId></ArticleIdList></Reference><Reference><Citation>Boill&#xe9;e S., Yamanaka K., Lobsiger C.S., Copeland N.G., Jenkins N.A., Kassiotis G., Kollias G., Cleveland D.W. Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia. Science. 2006;312:1389&#x2013;1392. doi: 10.1126/science.1123511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1123511</ArticleId><ArticleId IdType="pubmed">16741123</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Giorgio F.P., Boulting G.L., Bobrowicz S., Eggan K.C. Human Embryonic Stem Cell-Derived Motor Neurons Are Sensitive to the Toxic Effect of Glial Cells Carrying an ALS-Causing Mutation. Cell Stem Cell. 2008;3:637&#x2013;648. doi: 10.1016/j.stem.2008.09.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2008.09.017</ArticleId><ArticleId IdType="pubmed">19041780</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K., Chun S.J., Boillee S., Fujimori-Tonou N., Yamashita H., Gutmann D.H., Takahashi R., Misawa H., Cleveland D.W. Astrocytes as Determinants of Disease Progression in Inherited Amyotrophic Lateral Sclerosis. Nat. Neurosci. 2008;11:251&#x2013;253. doi: 10.1038/nn2047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn2047</ArticleId><ArticleId IdType="pmc">PMC3137510</ArticleId><ArticleId IdType="pubmed">18246065</ArticleId></ArticleIdList></Reference><Reference><Citation>Frakes A.E., Ferraiuolo L., Haidet-Phillips A.M., Schmelzer L., Braun L., Miranda C.J., Ladner K.J., Bevan A.K., Foust K.D., Godbout J.P., et al. Microglia Induce Motor Neuron Death via the Classical NF-&#x39a;B Pathway in Amyotrophic Lateral Sclerosis. Neuron. 2014;81:1009&#x2013;1023. doi: 10.1016/j.neuron.2014.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.01.013</ArticleId><ArticleId IdType="pmc">PMC3978641</ArticleId><ArticleId IdType="pubmed">24607225</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao B., Zhao W., Beers D.R., Henkel J.S., Appel S.H. Transformation from a Neuroprotective to a Neurotoxic Microglial Phenotype in a Mouse Model of ALS. Exp. Neurol. 2012;237:147&#x2013;152. doi: 10.1016/j.expneurol.2012.06.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2012.06.011</ArticleId><ArticleId IdType="pmc">PMC4126417</ArticleId><ArticleId IdType="pubmed">22735487</ArticleId></ArticleIdList></Reference><Reference><Citation>Maniatis S., &#xc4;ij&#xf6; T., Vickovic S., Braine C., Kang K., Mollbrink A., Fagegaltier D., Andrusivov&#xe1; &#x17d;., Saarenp&#xe4;&#xe4; S., Saiz-Castro G., et al. Spatiotemporal Dynamics of Molecular Pathology in Amyotrophic Lateral Sclerosis. Science. 2019;364:89&#x2013;93. doi: 10.1126/science.aav9776.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aav9776</ArticleId><ArticleId IdType="pubmed">30948552</ArticleId></ArticleIdList></Reference><Reference><Citation>Nutma E., Van Gent D., Amor S., Peferoen L.A.N. Cells Astrocyte and Oligodendrocyte Cross-Talk in the Central Nervous System. Cells. 2020;9:600. doi: 10.3390/cells9030600.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9030600</ArticleId><ArticleId IdType="pmc">PMC7140446</ArticleId><ArticleId IdType="pubmed">32138223</ArticleId></ArticleIdList></Reference><Reference><Citation>Rawji K.S., Gonzalez Martinez G.A., Sharma A., Franklin R.J.M. The Role of Astrocytes in Remyelination. Trends Neurosci. 2020;43:596&#x2013;607. doi: 10.1016/j.tins.2020.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2020.05.006</ArticleId><ArticleId IdType="pubmed">32620289</ArticleId></ArticleIdList></Reference><Reference><Citation>Lloyd A.F., Miron V.E. The Pro-Remyelination Properties of Microglia in the Central Nervous System. Nat. Rev. Neurol. 2019:29&#x2013;34. doi: 10.1038/s41582-019-0184-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-019-0184-2</ArticleId><ArticleId IdType="pubmed">31256193</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagemeyer N., Hanft K.M., Akriditou M.A., Unger N., Park E.S., Stanley E.R., Staszewski O., Dimou L., Prinz M. Microglia Contribute to Normal Myelinogenesis and to Oligodendrocyte Progenitor Maintenance during Adulthood. Acta Neuropathol. 2017;134:441&#x2013;458. doi: 10.1007/s00401-017-1747-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1747-1</ArticleId><ArticleId IdType="pmc">PMC5951721</ArticleId><ArticleId IdType="pubmed">28685323</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes A.N., Appel B. Microglia Phagocytose Myelin Sheaths to Modify Developmental Myelination. Nat. Neurosci. 2020;23:1055&#x2013;1066. doi: 10.1038/s41593-020-0654-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-0654-2</ArticleId><ArticleId IdType="pmc">PMC7483351</ArticleId><ArticleId IdType="pubmed">32632287</ArticleId></ArticleIdList></Reference><Reference><Citation>Camargo N., Goudriaan A., van Deijk A.-L.F., Otte W.M., Brouwers J.F., Lodder H., Gutmann D.H., Nave K.-A., Dijkhuizen R.M., Mansvelder H.D., et al. Oligodendroglial Myelination Requires Astrocyte-Derived Lipids. PLoS Biol. 2017;15:e1002605. doi: 10.1371/journal.pbio.1002605.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.1002605</ArticleId><ArticleId IdType="pmc">PMC5446120</ArticleId><ArticleId IdType="pubmed">28549068</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutta D.J., Woo D.H., Lee P.R., Pajevic S., Bukalo O., Huffman W.C., Wake H., Basser P.J., SheikhBahaei S., Lazarevic V., et al. Regulation of Myelin Structure and Conduction Velocity by Perinodal Astrocytes. Proc. Natl. Acad. Sci. USA. 2018;115:11832&#x2013;11837. doi: 10.1073/pnas.1811013115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1811013115</ArticleId><ArticleId IdType="pmc">PMC6243273</ArticleId><ArticleId IdType="pubmed">30373833</ArticleId></ArticleIdList></Reference><Reference><Citation>Lampron A., Larochelle A., Laflamme N., Pr&#xe9;fontaine P., Plante M.M., S&#xe1;nchez M.G., Wee Yong V., Stys P.K., Tremblay M.&#xc8;., Rivest S. Inefficient Clearance of Myelin Debris by Microglia Impairs Remyelinating Processes. J. Exp. Med. 2015;212:481&#x2013;495. doi: 10.1084/jem.20141656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20141656</ArticleId><ArticleId IdType="pmc">PMC4387282</ArticleId><ArticleId IdType="pubmed">25779633</ArticleId></ArticleIdList></Reference><Reference><Citation>Miron V.E. Microglia-Driven Regulation of Oligodendrocyte Lineage Cells, Myelination, and Remyelination. J. Leukoc. Biol. 2017;101:1103&#x2013;1108. doi: 10.1189/jlb.3RI1116-494R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.3RI1116-494R</ArticleId><ArticleId IdType="pubmed">28250011</ArticleId></ArticleIdList></Reference><Reference><Citation>Lombardi M., Parolisi R., Scaroni F., Bonfanti E., Gualerzi A., Gabrielli M., Kerlero de Rosbo N., Uccelli A., Giussani P., Viani P., et al. Detrimental and Protective Action of Microglial Extracellular Vesicles on Myelin Lesions: Astrocyte Involvement in Remyelination Failure. Acta Neuropathol. 2019;138:987&#x2013;1012. doi: 10.1007/s00401-019-02049-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-02049-1</ArticleId><ArticleId IdType="pmc">PMC6851224</ArticleId><ArticleId IdType="pubmed">31363836</ArticleId></ArticleIdList></Reference><Reference><Citation>Miron V.E., Boyd A., Zhao J.W., Yuen T.J., Ruckh J.M., Shadrach J.L., Van Wijngaarden P., Wagers A.J., Williams A., Franklin R.J.M., et al. M2 Microglia and Macrophages Drive Oligodendrocyte Differentiation during CNS Remyelination. Nat. Neurosci. 2013;16:1211&#x2013;1218. doi: 10.1038/nn.3469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3469</ArticleId><ArticleId IdType="pmc">PMC3977045</ArticleId><ArticleId IdType="pubmed">23872599</ArticleId></ArticleIdList></Reference><Reference><Citation>Raffaele S., Gelosa P., Bonfanti E., Lombardi M., Castiglioni L., Cimino M., Sironi L., Abbracchio M.P., Verderio C., Fumagalli M. Microglial Vesicles Improve Post-Stroke Recovery by Preventing Immune Cell Senescence and Favoring Oligodendrogenesis. Mol. Ther. 2020;29:1&#x2013;20. doi: 10.1016/j.ymthe.2020.12.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymthe.2020.12.009</ArticleId><ArticleId IdType="pmc">PMC8058432</ArticleId><ArticleId IdType="pubmed">33309882</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddelow S.A., Guttenplan K.A., Clarke L.E., Bennett F.C., Bohlen C.J., Schirmer L., Bennett M.L., M&#xfc;nch A.E., Chung W.S., Peterson T.C., et al. Neurotoxic Reactive Astrocytes Are Induced by Activated Microglia. Nature. 2017;541:481&#x2013;487. doi: 10.1038/nature21029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature21029</ArticleId><ArticleId IdType="pmc">PMC5404890</ArticleId><ArticleId IdType="pubmed">28099414</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers D.R., Zhao W., Liao B., Kano O., Wang J., Huang A., Appel S.H., Henkel J.S. Neuroinflammation Modulates Distinct Regional and Temporal Clinical Responses in ALS Mice. Brain. Behav. Immun. 2011;25:1025&#x2013;1035. doi: 10.1016/j.bbi.2010.12.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2010.12.008</ArticleId><ArticleId IdType="pmc">PMC3096756</ArticleId><ArticleId IdType="pubmed">21176785</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu I.M., Morimoto E.T.A., Goodarzi H., Liao J.T., O&#x2019;Keeffe S., Phatnani H.P., Muratet M., Carroll M.C., Levy S., Tavazoie S., et al. A Neurodegeneration-Specific Gene-Expression Signature of Acutely Isolated Microglia from an Amyotrophic Lateral Sclerosis Mouse Model. Cell Rep. 2013;4:385&#x2013;401. doi: 10.1016/j.celrep.2013.06.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2013.06.018</ArticleId><ArticleId IdType="pmc">PMC4272581</ArticleId><ArticleId IdType="pubmed">23850290</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xed;az-Amarilla P., Olivera-Bravo S., Trias E., Cragnolini A., Mart&#xed;nez-Palma L., Cassina P., Beckman J., Barbeito L. Phenotypically Aberrant Astrocytes That Promote Motoneuron Damage in a Model of Inherited Amyotrophic Lateral Sclerosis. Proc. Natl. Acad. Sci. USA. 2011;108:18126&#x2013;18131. doi: 10.1073/pnas.1110689108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1110689108</ArticleId><ArticleId IdType="pmc">PMC3207668</ArticleId><ArticleId IdType="pubmed">22010221</ArticleId></ArticleIdList></Reference><Reference><Citation>Guttenplan K.A., Weigel M.K., Adler D.I., Couthouis J., Liddelow S.A., Gitler A.D., Barres B.A. Knockout of Reactive Astrocyte Activating Factors Slows Disease Progression in an ALS Mouse Model. Nat. Commun. 2020;11:1&#x2013;9. doi: 10.1038/s41467-020-17514-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17514-9</ArticleId><ArticleId IdType="pmc">PMC7385161</ArticleId><ArticleId IdType="pubmed">32719333</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunha C., Santos C., Gomes C., Fernandes A., Correia A.M., Sebasti&#xe3;o A.M., Vaz A.R., Brites D. Downregulated Glia Interplay and Increased MiRNA-155 as Promising Markers to Track ALS at an Early Stage. Mol. Neurobiol. 2018;55:4207&#x2013;4224. doi: 10.1007/s12035-017-0631-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-017-0631-2</ArticleId><ArticleId IdType="pubmed">28612258</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandoorne T., De Bock K., Van Den Bosch L. Energy Metabolism in ALS: An Underappreciated Opportunity? Acta Neuropathol. 2018;135:489&#x2013;509. doi: 10.1007/s00401-018-1835-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1835-x</ArticleId><ArticleId IdType="pmc">PMC5978930</ArticleId><ArticleId IdType="pubmed">29549424</ArticleId></ArticleIdList></Reference><Reference><Citation>LeMasson G., Przedborski S., Abbott L.F. A Computational Model of Motor Neuron Degeneration. Neuron. 2014;83:975&#x2013;988. doi: 10.1016/j.neuron.2014.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.07.001</ArticleId><ArticleId IdType="pmc">PMC4167823</ArticleId><ArticleId IdType="pubmed">25088365</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips T., Rothstein J.D. Oligodendroglia: Metabolic Supporters of Neurons. J. Clin. Investig. 2017;127:3271&#x2013;3280. doi: 10.1172/JCI90610.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI90610</ArticleId><ArticleId IdType="pmc">PMC5669561</ArticleId><ArticleId IdType="pubmed">28862639</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosko L., Smith V.N., Yamazaki R., Huang J.K. Oligodendrocyte Bioenergetics in Health and Disease. Neuroscientist. 2019;25:334&#x2013;343. doi: 10.1177/1073858418793077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1073858418793077</ArticleId><ArticleId IdType="pmc">PMC6745601</ArticleId><ArticleId IdType="pubmed">30122106</ArticleId></ArticleIdList></Reference><Reference><Citation>Adiele R.C., Adiele C.A. Metabolic Defects in Multiple Sclerosis. Mitochondrion. 2019;44:7&#x2013;14. doi: 10.1016/j.mito.2017.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2017.12.005</ArticleId><ArticleId IdType="pubmed">29246870</ArticleId></ArticleIdList></Reference><Reference><Citation>Madsen P.M., Pinto M., Patel S., McCarthy S., Gao H., Taherian M., Karmally S., Pereira C.V., Dvoriantchikova G., Ivanov D., et al. Mitochondrial DNA Double-Strand Breaks in Oligodendrocytes Cause Demyelination, Axonal Injury, and CNS Inflammation. J. Neurosci. 2017;37:10185&#x2013;10199. doi: 10.1523/JNEUROSCI.1378-17.2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1378-17.2017</ArticleId><ArticleId IdType="pmc">PMC5647772</ArticleId><ArticleId IdType="pubmed">28931570</ArticleId></ArticleIdList></Reference><Reference><Citation>Marangon D., Boccazzi M., Lecca D., Fumagalli M. Regulation of Oligodendrocyte Functions: Targeting Lipid Metabolism and Extracellular Matrix for Myelin Repair. J. Clin. Med. 2020;9:470. doi: 10.3390/jcm9020470.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9020470</ArticleId><ArticleId IdType="pmc">PMC7073561</ArticleId><ArticleId IdType="pubmed">32046349</ArticleId></ArticleIdList></Reference><Reference><Citation>Montani L. Lipids in Regulating Oligodendrocyte Structure and Function. Semin. Cell Dev. Biol. 2020 doi: 10.1016/j.semcdb.2020.07.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2020.07.016</ArticleId><ArticleId IdType="pubmed">32912639</ArticleId></ArticleIdList></Reference><Reference><Citation>Saher G., Br&#xfc;gger B., Lappe-Siefke C., M&#xf6;bius W., Tozawa R.I., Wehr M.C., Wieland F., Ishibashi S., Nave K.A. High Cholesterol Level Is Essential for Myelin Membrane Growth. Nat. Neurosci. 2005;8:468&#x2013;475. doi: 10.1038/nn1426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1426</ArticleId><ArticleId IdType="pubmed">15793579</ArticleId></ArticleIdList></Reference><Reference><Citation>Berghoff S.A., Spieth L., Sun T., Hosang L., Schlaphoff L., Depp C., D&#xfc;king T., Winchenbach J., Neuber J., Ewers D., et al. Microglia Facilitate Repair of Demyelinated Lesions via Post-Squalene Sterol Synthesis. Nat. Neurosci. 2020;24:47&#x2013;60. doi: 10.1038/s41593-020-00757-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00757-6</ArticleId><ArticleId IdType="pmc">PMC7116742</ArticleId><ArticleId IdType="pubmed">33349711</ArticleId></ArticleIdList></Reference><Reference><Citation>Hubler Z., Allimuthu D., Bederman I., Elitt M.S., Madhavan M., Allan K.C., Shick H.E., Garrison E.T., Karl M., Factor D.C., et al. Accumulation of 8,9-Unsaturated Sterols Drives Oligodendrocyte Formation and Remyelination. Nature. 2018;560:372&#x2013;376. doi: 10.1038/s41586-018-0360-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0360-3</ArticleId><ArticleId IdType="pmc">PMC6423962</ArticleId><ArticleId IdType="pubmed">30046109</ArticleId></ArticleIdList></Reference><Reference><Citation>Voskuhl R.R., Itoh N., Tassoni A., Matsukawa M.A., Ren E., Tse V., Jang E., Suen T.T., Itoh Y. Gene Expression in Oligodendrocytes during Remyelination Reveals Cholesterol Homeostasis as a Therapeutic Target in Multiple Sclerosis. Proc. Natl. Acad. Sci. USA. 2019;116:10130&#x2013;10139. doi: 10.1073/pnas.1821306116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1821306116</ArticleId><ArticleId IdType="pmc">PMC6525478</ArticleId><ArticleId IdType="pubmed">31040210</ArticleId></ArticleIdList></Reference><Reference><Citation>Berghoff S.A., Gerndt N., Winchenbach J., Stumpf S.K., Hosang L., Odoardi F., Ruhwedel T., B&#xf6;hler C., Barrette B., Stassart R., et al. Dietary Cholesterol Promotes Repair of Demyelinated Lesions in the Adult Brain. Nat. Commun. 2017;8:1&#x2013;15. doi: 10.1038/ncomms14241.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms14241</ArticleId><ArticleId IdType="pmc">PMC5286209</ArticleId><ArticleId IdType="pubmed">28117328</ArticleId></ArticleIdList></Reference><Reference><Citation>Pegoretti V., Swanson K.A., Bethea J.R., Probert L., Eisel U.L.M., Fischer R. Inflammation and Oxidative Stress in Multiple Sclerosis: Consequences for Therapy Development. Oxid. Med. Cell. Longev. 2020;2020 doi: 10.1155/2020/7191080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/7191080</ArticleId><ArticleId IdType="pmc">PMC7240663</ArticleId><ArticleId IdType="pubmed">32454942</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrera-Juli&#xe1; S., Moreno M.L., Barrios C., de la Rubia Ort&#xed; J.E., Drehmer E. Antioxidant Alternatives in the Treatment of Amyotrophic Lateral Sclerosis: A Comprehensive Review. Front. Physiol. 2020;11:63. doi: 10.3389/fphys.2020.00063.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2020.00063</ArticleId><ArticleId IdType="pmc">PMC7016185</ArticleId><ArticleId IdType="pubmed">32116773</ArticleId></ArticleIdList></Reference><Reference><Citation>Back S.A., Gan X., Li Y., Rosenberg P.A., Volpe J.J. Maturation-Dependent Vulnerability of Oligodendrocytes to Oxidative Stress-Induced Death Caused by Glutathione Depletion. J. Neurosci. 1998;18:6241&#x2013;6253. doi: 10.1523/JNEUROSCI.18-16-06241.1998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.18-16-06241.1998</ArticleId><ArticleId IdType="pmc">PMC6793198</ArticleId><ArticleId IdType="pubmed">9698317</ArticleId></ArticleIdList></Reference><Reference><Citation>French H.M., Reid M., Mamontov P., Simmons R.A., Grinspan J.B. Oxidative Stress Disrupts Oligodendrocyte Maturation. J. Neurosci. Res. 2009;87:3076&#x2013;3087. doi: 10.1002/jnr.22139.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.22139</ArticleId><ArticleId IdType="pmc">PMC3138415</ArticleId><ArticleId IdType="pubmed">19479983</ArticleId></ArticleIdList></Reference><Reference><Citation>Elfawy H.A., Das B. Crosstalk between Mitochondrial Dysfunction, Oxidative Stress, and Age Related Neurodegenerative Disease: Etiologies and Therapeutic Strategies. Life Sci. 2019;218:165&#x2013;184. doi: 10.1016/j.lfs.2018.12.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2018.12.029</ArticleId><ArticleId IdType="pubmed">30578866</ArticleId></ArticleIdList></Reference><Reference><Citation>Fumagalli M., Lombardi M., Gressens P., Verderio C. How to Reprogram Microglia toward Beneficial Functions. Glia. 2018;66:2531&#x2013;2549. doi: 10.1002/glia.23484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23484</ArticleId><ArticleId IdType="pmc">PMC6585737</ArticleId><ArticleId IdType="pubmed">30195261</ArticleId></ArticleIdList></Reference><Reference><Citation>Apolloni S., Fabbrizio P., Parisi C., Amadio S., Volont&#xe9; C. Clemastine Confers Neuroprotection and Induces an Anti-Inflammatory Phenotype in SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis. Mol. Neurobiol. 2016;53:518&#x2013;531. doi: 10.1007/s12035-014-9019-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-014-9019-8</ArticleId><ArticleId IdType="pubmed">25482048</ArticleId></ArticleIdList></Reference><Reference><Citation>Apolloni S., Fabbrizio P., Amadio S., Volont&#xe9; C. Actions of the Antihistaminergic Clemastine on Presymptomatic SOD1-G93A Mice Ameliorate ALS Disease Progression. J. Neuroinflamm. 2016:1&#x2013;15. doi: 10.1186/s12974-016-0658-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0658-8</ArticleId><ArticleId IdType="pmc">PMC4994328</ArticleId><ArticleId IdType="pubmed">27549088</ArticleId></ArticleIdList></Reference><Reference><Citation>Mei F., Fancy S.P.J., Shen Y.A.A., Niu J., Zhao C., Presley B., Miao E., Lee S., Mayoral S.R., Redmond S.A., et al. Micropillar Arrays as a High-Throughput Screening Platform for Therapeutics in Multiple Sclerosis. Nat. Med. 2014;20:954&#x2013;960. doi: 10.1038/nm.3618.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.3618</ArticleId><ArticleId IdType="pmc">PMC4830134</ArticleId><ArticleId IdType="pubmed">24997607</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z., He Y., Fan S., Sun B. Clemastine Rescues Behavioral Changes and Enhances Remyelination in the Cuprizone Mouse Model of Demyelination. Neurosci. Bull. 2015;31:617&#x2013;625. doi: 10.1007/s12264-015-1555-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12264-015-1555-3</ArticleId><ArticleId IdType="pmc">PMC5563681</ArticleId><ArticleId IdType="pubmed">26253956</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F., Ren S.Y., Chen J.F., Liu K., Li R.X., Li Z.F., Hu B., Niu J.Q., Xiao L., Chan J.R., et al. Myelin Degeneration and Diminished Myelin Renewal Contribute to Age-Related Deficits in Memory. Nat. Neurosci. 2020;23:481&#x2013;486. doi: 10.1038/s41593-020-0588-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-0588-8</ArticleId><ArticleId IdType="pmc">PMC7306053</ArticleId><ArticleId IdType="pubmed">32042174</ArticleId></ArticleIdList></Reference><Reference><Citation>Cree B.A.C., Niu J., Hoi K.K., Zhao C., Caganap S.D., Henry R.G., Dao D.Q., Zollinger D.R., Mei F., Shen Y.-A.A., et al. Clemastine Rescues Myelination Defects and Promotes Functional Recovery in Hypoxic Brain Injury. Brain. 2018;141:85&#x2013;98. doi: 10.1093/brain/awx312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awx312</ArticleId><ArticleId IdType="pmc">PMC6394402</ArticleId><ArticleId IdType="pubmed">29244098</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Dupree J.L., Gacias M., Frawley R., Sikder T., Naik P., Casaccia P. Clemastine Enhances Myelination in the Prefrontal Cortex and Rescues Behavioral Changes in Socially Isolated Mice. J. Neurosci. 2016;36:957&#x2013;962. doi: 10.1523/JNEUROSCI.3608-15.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3608-15.2016</ArticleId><ArticleId IdType="pmc">PMC4719024</ArticleId><ArticleId IdType="pubmed">26791223</ArticleId></ArticleIdList></Reference><Reference><Citation>Green A.J., Gelfand J.M., Cree B.A., Bevan C., Boscardin W.J., Mei F., Inman J., Arnow S., Devereux M., Abounasr A., et al. Clemastine Fumarate as a Remyelinating Therapy for Multiple Sclerosis (ReBUILD): A Randomised, Controlled, Double-Blind, Crossover Trial. Lancet. 2017;390:2481&#x2013;2489. doi: 10.1016/S0140-6736(17)32346-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)32346-2</ArticleId><ArticleId IdType="pubmed">29029896</ArticleId></ArticleIdList></Reference><Reference><Citation>Riancho J., Ruiz-Soto M., Berciano M.T., Berciano J., Lafarga M. Neuroprotective Effect of Bexarotene in the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis. Front. Cell. Neurosci. 2015;9:1. doi: 10.3389/fncel.2015.00250.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00250</ArticleId><ArticleId IdType="pmc">PMC4486838</ArticleId><ArticleId IdType="pubmed">26190974</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J.K., Jarjour A.A., Oumesmar B.N., Kerninon C., Williams A., Krezel W., Kagechika H., Bauer J., Zhao C., Van Evercooren A.B., et al. Retinoid X Receptor Gamma Signaling Accelerates CNS Remyelination. Nat. Neurosci. 2011;14:45&#x2013;55. doi: 10.1038/nn.2702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2702</ArticleId><ArticleId IdType="pmc">PMC4013508</ArticleId><ArticleId IdType="pubmed">21131950</ArticleId></ArticleIdList></Reference><Reference><Citation>De La Fuente A.G., Errea O., Van Wijngaarden P., Gonzalez G.A., Kerninon C., Jarjour A.A., Lewis H.J., Jones C.A., Nait-Oumesmar B., Zhao C., et al. Vitamin D Receptor-Retinoid X Receptor Heterodimer Signaling Regulates Oligodendrocyte Progenitor Cell Differentiation. J. Cell Biol. 2015;211:975&#x2013;985. doi: 10.1083/jcb.201505119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201505119</ArticleId><ArticleId IdType="pmc">PMC4674280</ArticleId><ArticleId IdType="pubmed">26644513</ArticleId></ArticleIdList></Reference><Reference><Citation>Natrajan M.S., de la Fuente A.G., Crawford A.H., Linehan E., Nu&#xf1;ez V., Johnson K.R., Wu T., Fitzgerald D.C., Ricote M., Bielekova B., et al. Retinoid X Receptor Activation Reverses Age-Related Deficiencies in Myelin Debris Phagocytosis and Remyelination. Brain. 2015;138:3581&#x2013;3597. doi: 10.1093/brain/awv289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awv289</ArticleId><ArticleId IdType="pmc">PMC4668920</ArticleId><ArticleId IdType="pubmed">26463675</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilyasov A.A., Milligan C.E., Pharr E.P., Howlett A.C. The Endocannabinoid System and Oligodendrocytes in Health and Disease. Front. Neurosci. 2018;12:733. doi: 10.3389/fnins.2018.00733.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00733</ArticleId><ArticleId IdType="pmc">PMC6214135</ArticleId><ArticleId IdType="pubmed">30416422</ArticleId></ArticleIdList></Reference><Reference><Citation>Feli&#xfa; A., Del R&#xed;o I.B., Carrillo-Salinas F.J., Hern&#xe1;ndez-Torres G., Mestre L., Puente N., Ortega-Guti&#xe9;rrez S., L&#xf3;pez-Rodr&#xed;guez M.L., Grandes P., Mecha M., et al. 2-Arachidonoylglycerol Reduces Proteoglycans and Enhances Remyelination in a Progressive Model of Demyelination. J. Neurosci. 2017;37:8385&#x2013;8398. doi: 10.1523/JNEUROSCI.2900-16.2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2900-16.2017</ArticleId><ArticleId IdType="pmc">PMC6596867</ArticleId><ArticleId IdType="pubmed">28751457</ArticleId></ArticleIdList></Reference><Reference><Citation>Huerga-G&#xf3;mez A., Aguado T., S&#xe1;nchez-de la Torre A., Bernal-Chico A., Matute C., Mato S., Guzm&#xe1;n M., Galve-Roperh I., Palazuelos J. &#x394; 9 -Tetrahydrocannabinol Promotes Oligodendrocyte Development and CNS Myelination in Vivo. Glia. 2021;69:532&#x2013;545. doi: 10.1002/glia.23911.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23911</ArticleId><ArticleId IdType="pmc">PMC7821226</ArticleId><ArticleId IdType="pubmed">32956517</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J., Fang Y., Chen T., Guo J., Yan J., Song S., Zhang L., Liao H. WIN55, 212-2 Promotes Differentiation of Oligodendrocyte Precursor Cells and Improve Remyelination through Regulation of the Phosphorylation Level of the ERK 1/2 via Cannabinoid Receptor 1 after Stroke-Induced Demyelination. Brain Res. 2013;1491:225&#x2013;235. doi: 10.1016/j.brainres.2012.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2012.11.006</ArticleId><ArticleId IdType="pubmed">23148948</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi S., Bernardi G., Centonze D. The Endocannabinoid System in the Inflammatory and Neurodegenerative Processes of Multiple Sclerosis and of Amyotrophic Lateral Sclerosis. Exp. Neurol. 2010;224:92&#x2013;102. doi: 10.1016/j.expneurol.2010.03.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2010.03.030</ArticleId><ArticleId IdType="pubmed">20353778</ArticleId></ArticleIdList></Reference><Reference><Citation>Espejo-Porras F., Piscitelli F., Verde R., Ramos J.A., Di Marzo V., de Lago E., Fern&#xe1;ndez-Ruiz J. Changes in the Endocannabinoid Signaling System in CNS Structures of TDP-43 Transgenic Mice: Relevance for a Neuroprotective Therapy in TDP-43-Related Disorders. J. Neuroimmune Pharmacol. 2015;10:233&#x2013;244. doi: 10.1007/s11481-015-9602-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-015-9602-4</ArticleId><ArticleId IdType="pubmed">25819934</ArticleId></ArticleIdList></Reference><Reference><Citation>Carter G.T., McLaughlin R.J., Cuttler C., Sauber G.J., Weeks D.L., Hillard C.J., Weiss M.D. Endocannabinoids and Related Lipids in Serum from Patients with Amyotrophic Lateral Sclerosis. Muscle Nerve. 2021;63:120&#x2013;126. doi: 10.1002/mus.27096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.27096</ArticleId><ArticleId IdType="pubmed">33094490</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Mora G., Lauria G. Pain in Amyotrophic Lateral Sclerosis. Lancet Neurol. 2017;16:144&#x2013;157. doi: 10.1016/S1474-4422(16)30358-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(16)30358-1</ArticleId><ArticleId IdType="pubmed">27964824</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer T., Funke A., M&#xfc;nch C., Kettemann D., Maier A., Walter B., Thomas A., Spittel S. Real World Experience of Patients with Amyotrophic Lateral Sclerosis (ALS) in the Treatment of Spasticity Using Tetrahydrocannabinol:Cannabidiol (THC:CBD) BMC Neurol. 2019;19:222. doi: 10.1186/s12883-019-1443-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-019-1443-y</ArticleId><ArticleId IdType="pmc">PMC6732193</ArticleId><ArticleId IdType="pubmed">31493784</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilsland L.G., Dick J.R.T., Pryce G., Petrosino S., Di Marzo V., Baker D., Greensmith L. Increasing Cannabinoid Levels by Pharmacological and Genetic Manipulation Delays Disease Progression in SOD1 Mice. FASEB J. 2006;20:1003&#x2013;1005. doi: 10.1096/fj.05-4743fje.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.05-4743fje</ArticleId><ArticleId IdType="pubmed">16571781</ArticleId></ArticleIdList></Reference><Reference><Citation>Espejo-Porras F., Garc&#xed;a-Toscano L., Rodr&#xed;guez-Cueto C., Santos-Garc&#xed;a I., de Lago E., Fernandez-Ruiz J. Targeting Glial Cannabinoid CB2 Receptors to Delay the Progression of the Pathological Phenotype in TDP-43 (A315T) Transgenic Mice, a Model of Amyotrophic Lateral Sclerosis. Br. J. Pharmacol. 2019;176:1585&#x2013;1600. doi: 10.1111/bph.14216.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.14216</ArticleId><ArticleId IdType="pmc">PMC6487601</ArticleId><ArticleId IdType="pubmed">29574689</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J.J. Overview of Current and Emerging Therapies for Amyotrophic Lateral Sclerosis. Am. J. Manag. Care. 2020;26:S191&#x2013;S197.</Citation><ArticleIdList><ArticleId IdType="pubmed">32840332</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyamoto N., Maki T., Pham L.D.D., Hayakawa K., Seo J.H., Mandeville E.T., Mandeville J.B., Kim K.W., Lo E.H., Arai K. Oxidative Stress Interferes with White Matter Renewal after Prolonged Cerebral Hypoperfusion in Mice. Stroke. 2013;44:3516&#x2013;3521. doi: 10.1161/STROKEAHA.113.002813.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.113.002813</ArticleId><ArticleId IdType="pmc">PMC3985753</ArticleId><ArticleId IdType="pubmed">24072001</ArticleId></ArticleIdList></Reference><Reference><Citation>Takase H., Liang A.C., Miyamoto N., Hamanaka G., Ohtomo R., Maki T., Pham L.D.D., Lok J., Lo E.H., Arai K. Protective Effects of a Radical Scavenger Edaravone on Oligodendrocyte Precursor Cells against Oxidative Stress. Neurosci. Lett. 2018;668:120&#x2013;125. doi: 10.1016/j.neulet.2018.01.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2018.01.018</ArticleId><ArticleId IdType="pmc">PMC5829007</ArticleId><ArticleId IdType="pubmed">29337010</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng T., Yamashita T., Sasaki R., Tadokoro K., Matsumoto N., Hishikawa N., Abe K. Protective Effects of Edaravone on White Matter Pathology in a Novel Mouse Model of Alzheimer&#x2019;s Disease with Chronic Cerebral Hypoperfusion. J. Cereb. Blood Flow Metab. 2020:271678X20968927. doi: 10.1177/0271678X20968927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0271678X20968927</ArticleId><ArticleId IdType="pubmed">33106078</ArticleId></ArticleIdList></Reference><Reference><Citation>Eleuteri C., Olla S., Veroni C., Umeton R., Mechelli R., Romano S., Buscarinu M.C., Ferrari F., Cal&#xf2; G., Ristori G., et al. A Staged Screening of Registered Drugs Highlights Remyelinating Drug Candidates for Clinical Trials. Sci. Rep. 2017;7:1&#x2013;15. doi: 10.1038/srep45780.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep45780</ArticleId><ArticleId IdType="pmc">PMC5384285</ArticleId><ArticleId IdType="pubmed">28387380</ArticleId></ArticleIdList></Reference><Reference><Citation>Merten N., Fischer J., Simon K., Zhang L., Schr&#xf6;der R., Peters L., Letombe A.G., Hennen S., Schrage R., B&#xf6;defeld T., et al. Repurposing HAMI3379 to Block GPR17 and Promote Rodent and Human Oligodendrocyte Differentiation. Cell Chem. Biol. 2018;25:775&#x2013;786.e5. doi: 10.1016/j.chembiol.2018.03.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chembiol.2018.03.012</ArticleId><ArticleId IdType="pmc">PMC6685917</ArticleId><ArticleId IdType="pubmed">29706593</ArticleId></ArticleIdList></Reference><Reference><Citation>Ou Z., Sun Y., Lin L., You N., Liu X., Li H., Ma Y., Cao L., Han Y., Liu M., et al. Olig2-Targeted G-Protein-Coupled Receptor Gpr17 Regulates Oligodendrocyte Survival in Response to Lysolecithin-Induced Demyelination. J. Neurosci. 2016;36:10560&#x2013;10573. doi: 10.1523/JNEUROSCI.0898-16.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0898-16.2016</ArticleId><ArticleId IdType="pmc">PMC6601930</ArticleId><ArticleId IdType="pubmed">27733608</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelosa P., Bonfanti E., Castiglioni L., Delgado-Garcia J.M., Gruart A., Fontana L., Gotti M., Tremoli E., Lecca D., Fumagalli M., et al. Improvement of Fiber Connectivity and Functional Recovery after Stroke by Montelukast, an Available and Safe Anti-Asthmatic Drug. Pharmacol. Res. 2019;142:223&#x2013;236. doi: 10.1016/j.phrs.2019.02.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2019.02.025</ArticleId><ArticleId IdType="pubmed">30818044</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., He X., Meng H., Li Y., Dmitriev P., Tian F., Page J.C., Lu Q.R., He Z. Robust Myelination of Regenerated Axons Induced by Combined Manipulations of GPR17 and Microglia. Neuron. 2020;108:876&#x2013;886.e4. doi: 10.1016/j.neuron.2020.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2020.09.016</ArticleId><ArticleId IdType="pmc">PMC7736523</ArticleId><ArticleId IdType="pubmed">33108748</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniele S., Trincavelli M.L., Gabelloni P., Lecca D., Rosa P., Abbracchio M.P., Martini C. Agonist-Induced Desensitization/Resensitization of Human G Protein-Coupled Receptor 17: A Functional Cross-Talk between Purinergic and Cysteinyl- Leukotriene Ligands. J. Pharmacol. Exp. Ther. 2011;338:559&#x2013;567. doi: 10.1124/jpet.110.178715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.110.178715</ArticleId><ArticleId IdType="pubmed">21531793</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniele S., Trincavelli M.L., Fumagalli M., Zappelli E., Lecca D., Bonfanti E., Campiglia P., Abbracchio M.P., Martini C. Does GRK-&#x3b2; Arrestin Machinery Work as a &#x201c;Switch on&#x201d; for GPR17-Mediated Activation of Intracellular Signaling Pathways? Cell. Signal. 2014;26:1310&#x2013;1325. doi: 10.1016/j.cellsig.2014.02.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2014.02.016</ArticleId><ArticleId IdType="pubmed">24613411</ArticleId></ArticleIdList></Reference><Reference><Citation>Capelli D., Parravicini C., Pochetti G., Montanari R., Temporini C., Rabuffetti M., Trincavelli M.L., Daniele S., Fumagalli M., Saporiti S., et al. Surface Plasmon Resonance as a Tool for Ligand Binding Investigation of Engineered GPR17 Receptor, a G Protein Coupled Receptor Involved in Myelination. Front. Chem. 2019;7:910. doi: 10.3389/fchem.2019.00910.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fchem.2019.00910</ArticleId><ArticleId IdType="pmc">PMC6966494</ArticleId><ArticleId IdType="pubmed">31998697</ArticleId></ArticleIdList></Reference><Reference><Citation>Parravicini C., Lecca D., Marangon D., Coppolino G.T., Daniele S., Bonfanti E., Fumagalli M., Raveglia L., Martini C., Gianazza E., et al. Development of the First in Vivo GPR17 Ligand through an Iterative Drug Discovery Pipeline: A Novel Disease-Modifying Strategy for Multiple Sclerosis. PLoS ONE. 2020;15:e0231483. doi: 10.1371/journal.pone.0231483.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0231483</ArticleId><ArticleId IdType="pmc">PMC7176092</ArticleId><ArticleId IdType="pubmed">32320409</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfeiffer R.M., Mayer B., Kuncl R.W., Check D.P., Cahoon E.K., Rivera D.R., Freedman D.M. Identifying Potential Targets for Prevention and Treatment of Amyotrophic Lateral Sclerosis Based on a Screen of Medicare Prescription Drugs. Amyotroph. Lateral Scler. Front. Degener. 2020;21:235&#x2013;245. doi: 10.1080/21678421.2019.1682613.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1682613</ArticleId><ArticleId IdType="pubmed">31684770</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen P.-C., Hsieh Y.-C., Huang C.-C., Hu C.-J. Tamoxifen for Amyotrophic Lateral Sclerosis. Medicine (Baltimore) 2020;99:e20423. doi: 10.1097/MD.0000000000020423.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000020423</ArticleId><ArticleId IdType="pubmed">32481440</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang I.F., Guo B.S., Liu Y.C., Wu C.C., Yang C.H., Tsai K.J., Shen C.K.J. Autophagy Activators Rescue and Alleviate Pathogenesis of a Mouse Model with Proteinopathies of the TAR DNA-Binding Protein 43. Proc. Natl. Acad. Sci. USA. 2012;109:15024&#x2013;15029. doi: 10.1073/pnas.1206362109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1206362109</ArticleId><ArticleId IdType="pmc">PMC3443184</ArticleId><ArticleId IdType="pubmed">22932872</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez G.A., Hofer M.P., Syed Y.A., Amaral A.I., Rundle J., Rahman S., Zhao C., Kotter M.R.N. Tamoxifen Accelerates the Repair of Demyelinated Lesions in the Central Nervous System. Sci. Rep. 2016;6:1&#x2013;13. doi: 10.1038/srep31599.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep31599</ArticleId><ArticleId IdType="pmc">PMC4995517</ArticleId><ArticleId IdType="pubmed">27554391</ArticleId></ArticleIdList></Reference><Reference><Citation>Rankin K.A., Mei F., Kim K., Shen Y.A.A., Mayoral S.R., Desponts C., Lorrain D.S., Green A.J., Baranzini S.E., Chan J.R., et al. Selective Estrogen Receptor Modulators Enhance CNS Remyelination Independent of Estrogen Receptors. J. Neurosci. 2019;39:2184&#x2013;2194. doi: 10.1523/JNEUROSCI.1530-18.2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1530-18.2019</ArticleId><ArticleId IdType="pmc">PMC6433770</ArticleId><ArticleId IdType="pubmed">30696729</ArticleId></ArticleIdList></Reference><Reference><Citation>Sedel F., Bernard D., Mock D.M., Tourbah A. Targeting Demyelination and Virtual Hypoxia with High-Dose Biotin as a Treatment for Progressive Multiple Sclerosis. Neuropharmacology. 2016;110:644&#x2013;653. doi: 10.1016/j.neuropharm.2015.08.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2015.08.028</ArticleId><ArticleId IdType="pubmed">26327679</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui Q.-L., Lin Y.H., Xu Y.K.T., Fernandes M.G.F., Rao V.T.S., Kennedy T.E., Antel J. Effects of Biotin on Survival, Ensheathment, and ATP Production by Oligodendrocyte Lineage Cells in Vitro. PLoS ONE. 2020;15:e0233859. doi: 10.1371/journal.pone.0233859.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0233859</ArticleId><ArticleId IdType="pmc">PMC7259710</ArticleId><ArticleId IdType="pubmed">32470040</ArticleId></ArticleIdList></Reference><Reference><Citation>Sedel F., Papeix C., Bellanger A., Touitou V., Lebrun-Frenay C., Galanaud D., Gout O., Lyon-Caen O., Tourbah A. High Doses of Biotin in Chronic Progressive Multiple Sclerosis: A Pilot Study. Mult. Scler. Relat. Disord. 2015;4:159&#x2013;169. doi: 10.1016/j.msard.2015.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.msard.2015.01.005</ArticleId><ArticleId IdType="pubmed">25787192</ArticleId></ArticleIdList></Reference><Reference><Citation>Tourbah A., Lebrun-Frenay C., Edan G., Clanet M., Papeix C., Vukusic S., De S&#xe8;ze J., Debouverie M., Gout O., Clavelou P., et al. MD1003 (High-Dose Biotin) for the Treatment of Progressive Multiple Sclerosis: A Randomised, Double-Blind, Placebo-Controlled Study. Mult. Scler. 2016;22:1719&#x2013;1731. doi: 10.1177/1352458516667568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1352458516667568</ArticleId><ArticleId IdType="pmc">PMC5098693</ArticleId><ArticleId IdType="pubmed">27589059</ArticleId></ArticleIdList></Reference><Reference><Citation>Tourbah A., Gout O., Vighetto A., Deburghgraeve V., Pelletier J., Papeix C., Lebrun-Frenay C., Labauge P., Brassat D., Toosy A., et al. MD1003 (High-Dose Pharmaceutical-Grade Biotin) for the Treatment of Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study. CNS Drugs. 2018;32:661&#x2013;672. doi: 10.1007/s40263-018-0528-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40263-018-0528-2</ArticleId><ArticleId IdType="pmc">PMC6061426</ArticleId><ArticleId IdType="pubmed">29808469</ArticleId></ArticleIdList></Reference><Reference><Citation>Juntas-Morales R., Pageot N., Bendarraz A., Alphand&#xe9;ry S., Sedel F., Seigle S., Camu W. High-Dose Pharmaceutical Grade Biotin (MD1003) in Amyotrophic Lateral Sclerosis: A Pilot Study. EClinicalMedicine. 2020;19:100254. doi: 10.1016/j.eclinm.2019.100254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2019.100254</ArticleId><ArticleId IdType="pmc">PMC7046518</ArticleId><ArticleId IdType="pubmed">32140672</ArticleId></ArticleIdList></Reference><Reference><Citation>Cree B.A.C., Cutter G., Wolinsky J.S., Freedman M.S., Comi G., Giovannoni G., Hartung H.P., Arnold D., Kuhle J., Block V., et al. Safety and Efficacy of MD1003 (High-Dose Biotin) in Patients with Progressive Multiple Sclerosis (SPI2): A Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial. Lancet Neurol. 2020;19:988&#x2013;997. doi: 10.1016/S1474-4422(20)30347-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30347-1</ArticleId><ArticleId IdType="pubmed">33222767</ArticleId></ArticleIdList></Reference><Reference><Citation>Khasnavis S., Jana A., Roy A., Mazumder M., Bhushan B., Wood T., Ghosh S., Watson R., Pahan K. Suppression of Nuclear Factor-&#x39a;B Activation and Inflammation in Microglia by Physically Modified Saline. J. Biol. Chem. 2012;287:29529&#x2013;29542. doi: 10.1074/jbc.M111.338012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.338012</ArticleId><ArticleId IdType="pmc">PMC3436140</ArticleId><ArticleId IdType="pubmed">22753407</ArticleId></ArticleIdList></Reference><Reference><Citation>Khasnavis S., Roy A., Ghosh S., Watson R., Pahan K. Protection of Dopaminergic Neurons in a Mouse Model of Parkinson&#x2019;s Disease by a Physically-Modified Saline Containing Charge-Stabilized Nanobubbles. J. Neuroimmune Pharmacol. 2014;9:218&#x2013;232. doi: 10.1007/s11481-013-9503-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-013-9503-3</ArticleId><ArticleId IdType="pubmed">24122363</ArticleId></ArticleIdList></Reference><Reference><Citation>Modi K.K., Jana A., Ghosh S., Watson R., Pahan K. A Physically-Modified Saline Suppresses Neuronal Apoptosis, Attenuates Tau Phosphorylation and Protects Memory in an Animal Model of Alzheimer&#x2019;s Disease. PLoS ONE. 2014;9:e103606. doi: 10.1371/journal.pone.0103606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0103606</ArticleId><ArticleId IdType="pmc">PMC4121132</ArticleId><ArticleId IdType="pubmed">25089827</ArticleId></ArticleIdList></Reference><Reference><Citation>Rangasamy S.B., Ghosh S., Pahan K. RNS60, a Physically-Modified Saline, Inhibits Glial Activation, Suppresses Neuronal Apoptosis and Protects Memory in a Mouse Model of Traumatic Brain Injury. Exp. Neurol. 2020;328:113279. doi: 10.1016/j.expneurol.2020.113279.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2020.113279</ArticleId><ArticleId IdType="pubmed">32151546</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi S., Yu E., Rabello G., Merlo S., Zemmar A., Walton K.D., Moreno H., Moreira J.E., Sugimori M., Llin&#xe1;s R.R. Enhanced Synaptic Transmission at the Squid Giant Synapse by Artificial Seawater Based on Physically Modified Saline. Front. Synaptic Neurosci. 2014;6:2. doi: 10.3389/fnsyn.2014.00002.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnsyn.2014.00002</ArticleId><ArticleId IdType="pmc">PMC3921564</ArticleId><ArticleId IdType="pubmed">24575037</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi S., Yu E., Kim D.-S., Sugimori M., Llin&#xe1;s R.R. RNS60, a Charge-Stabilized Nanostructure Saline Alters Xenopus Laevis Oocyte Biophysical Membrane Properties by Enhancing Mitochondrial ATP Production. Physiol. Rep. 2015;3:e12261. doi: 10.14814/phy2.12261.</Citation><ArticleIdList><ArticleId IdType="doi">10.14814/phy2.12261</ArticleId><ArticleId IdType="pmc">PMC4393147</ArticleId><ArticleId IdType="pubmed">25742953</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandra G., Kundu M., Rangasamy S.B., Dasarathy S., Ghosh S., Watson R., Pahan K. Increase in Mitochondrial Biogenesis in Neuronal Cells by RNS60, a Physically-Modified Saline, via Phosphatidylinositol 3-Kinase-Mediated Upregulation of PGC1&#x3b1;. J. Neuroimmune Pharmacol. 2018;13:143&#x2013;162. doi: 10.1007/s11481-017-9771-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-017-9771-4</ArticleId><ArticleId IdType="pmc">PMC5928179</ArticleId><ArticleId IdType="pubmed">29188424</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao V.T.S., Khan D., Jones R.G., Nakamura D.S., Kennedy T.E., Cui Q.L., Rone M.B., Healy L.M., Watson R., Ghosh S., et al. Potential Benefit of the Charge-Stabilized Nanostructure Saline RNS60 for Myelin Maintenance and Repair. Sci. Rep. 2016;6:1&#x2013;8. doi: 10.1038/srep30020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep30020</ArticleId><ArticleId IdType="pmc">PMC4958964</ArticleId><ArticleId IdType="pubmed">27451946</ArticleId></ArticleIdList></Reference><Reference><Citation>Jana M., Ghosh S., Pahan K. Upregulation of Myelin Gene Expression by a Physically-Modified Saline via Phosphatidylinositol 3-Kinase-Mediated Activation of CREB: Implications for Multiple Sclerosis. Neurochem. Res. 2018;43:407&#x2013;419. doi: 10.1007/s11064-017-2435-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-017-2435-1</ArticleId><ArticleId IdType="pmc">PMC5799355</ArticleId><ArticleId IdType="pubmed">29143164</ArticleId></ArticleIdList></Reference><Reference><Citation>Mondal S., Martinson J.A., Ghosh S., Watson R., Pahan K. Protection of Tregs, Suppression of Th1 and Th17 Cells, and Amelioration of Experimental Allergic Encephalomyelitis by a Physically-Modified Saline. PLoS ONE. 2012;7:e51869. doi: 10.1371/journal.pone.0051869.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0051869</ArticleId><ArticleId IdType="pmc">PMC3527485</ArticleId><ArticleId IdType="pubmed">23284794</ArticleId></ArticleIdList></Reference><Reference><Citation>Mondal S., Rangasamy S.B., Ghosh S., Watson R.L., Pahan K. Nebulization of RNS60, a Physically-Modified Saline, Attenuates the Adoptive Transfer of Experimental Allergic Encephalomyelitis in Mice: Implications for Multiple Sclerosis Therapy. Neurochem. Res. 2017;42:1555&#x2013;1570. doi: 10.1007/s11064-017-2214-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-017-2214-z</ArticleId><ArticleId IdType="pubmed">28271325</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallarola A., Sironi F., Tortarolo M., Gatto N., De Gioia R., Pasetto L., De Paola M., Mariani A., Ghosh S., Watson R., et al. RNS60 Exerts Therapeutic Effects in the SOD1 ALS Mouse Model through Protective Glia and Peripheral Nerve Rescue. J. Neuroinflammation. 2018;15:1&#x2013;22. doi: 10.1186/s12974-018-1101-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-018-1101-0</ArticleId><ArticleId IdType="pmc">PMC5833072</ArticleId><ArticleId IdType="pubmed">29495962</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganoni S., Alshikho M.J., Luppino S., Chan J., Pothier L., Schoenfeld D., Andres P.L., Babu S., Z&#xfc;rcher N.R., Loggia M.L., et al. A Pilot Trial of RNS60 in Amyotrophic Lateral Sclerosis. Muscle Nerve. 2019;59:303&#x2013;308. doi: 10.1002/mus.26385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26385</ArticleId><ArticleId IdType="pmc">PMC6379136</ArticleId><ArticleId IdType="pubmed">30458059</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen X., Liu W., Gao X., Lu Z., Wu X., Gao X. Mechanisms of Oxidase and Superoxide Dismutation-like Activities of Gold, Silver, Platinum, and Palladium, and Their Alloys: A General Way to the Activation of Molecular Oxygen. J. Am. Chem. Soc. 2015;137:15882&#x2013;15891. doi: 10.1021/jacs.5b10346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jacs.5b10346</ArticleId><ArticleId IdType="pubmed">26642084</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang X., El-Sayed I.H., Yi X., El-Sayed M.A. Gold Nanoparticles: Catalyst for the Oxidation of NADH to NAD+ J. Photochem. Photobiol. B Biol. 2005;81:76&#x2013;83. doi: 10.1016/j.jphotobiol.2005.05.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jphotobiol.2005.05.010</ArticleId><ArticleId IdType="pubmed">16125965</ArticleId></ArticleIdList></Reference><Reference><Citation>Harlan B.A., Killoy K.M., Pehar M., Liu L., Auwerx J., Vargas M.R. Evaluation of the NAD+ Biosynthetic Pathway in ALS Patients and Effect of Modulating NAD+ Levels in HSOD1-Linked ALS Mouse Models. Exp. Neurol. 2020;327:113219. doi: 10.1016/j.expneurol.2020.113219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2020.113219</ArticleId><ArticleId IdType="pmc">PMC7089832</ArticleId><ArticleId IdType="pubmed">32014438</ArticleId></ArticleIdList></Reference><Reference><Citation>He W., Zhou Y.T., Wamer W.G., Hu X., Wu X., Zheng Z., Boudreau M.D., Yin J.J. Intrinsic Catalytic Activity of Au Nanoparticles with Respect to Hydrogen Peroxide Decomposition and Superoxide Scavenging. Biomaterials. 2013;34:765&#x2013;773. doi: 10.1016/j.biomaterials.2012.10.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biomaterials.2012.10.010</ArticleId><ArticleId IdType="pubmed">23103160</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y., Ren J., Qu X. Nano-Gold as Artificial Enzymes: Hidden Talents. Adv. Mater. 2014;26:4200&#x2013;4217. doi: 10.1002/adma.201400238.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/adma.201400238</ArticleId><ArticleId IdType="pubmed">24692212</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson A.P., Zhang J.Z., Titus H.E., Karl M., Merzliakov M., Dorfman A.R., Karlik S., Stewart M.G., Watt R.K., Facer B.D., et al. Nanocatalytic Activity of Clean-Surfaced, Faceted Nanocrystalline Gold Enhances Remyelination in Animal Models of Multiple Sclerosis. Sci. Rep. 2020;10:1&#x2013;16. doi: 10.1038/s41598-020-58709-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-58709-w</ArticleId><ArticleId IdType="pmc">PMC7010780</ArticleId><ArticleId IdType="pubmed">32041968</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonneman A., Robberecht W., Van Den Bosch L. The Role of Oligodendroglial Dysfunction in Amyotrophic Lateral Sclerosis. Neurodegener. Dis. Manag. 2014;4:223&#x2013;239. doi: 10.2217/nmt.14.21.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/nmt.14.21</ArticleId><ArticleId IdType="pubmed">25095817</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenfeld J. Multi-Drug Therapy in Amyotrophic Lateral Sclerosis: The Case for a Multi-Drug Approach. Muscle Nerve. 2004;30:673&#x2013;675. doi: 10.1002/mus.20186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.20186</ArticleId><ArticleId IdType="pubmed">15452840</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan M.C., Vucic S., Talbot K., McDermott C.J., Hardiman O., Shefner J.M., Al-Chalabi A., Huynh W., Cudkowicz M., Talman P., et al. Improving Clinical Trial Outcomes in Amyotrophic Lateral Sclerosis. Nat. Rev. Neurol. 2021;17:104&#x2013;108. doi: 10.1038/s41582-020-00434-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-020-00434-z</ArticleId><ArticleId IdType="pmc">PMC7747476</ArticleId><ArticleId IdType="pubmed">33340024</ArticleId></ArticleIdList></Reference><Reference><Citation>Chanoumidou K., Mozafari S., Baron-Van Evercooren A., Kuhlmann T. Stem Cell Derived Oligodendrocytes to Study Myelin Diseases. Glia. 2020;68:705&#x2013;720. doi: 10.1002/glia.23733.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23733</ArticleId><ArticleId IdType="pubmed">31633852</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>